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ABSTRACT 
 Autism Spectrum Disorders (ASDs) involve deficits in social and communication 
abilities and the presence of repetitive and restricted behaviors, and affect approximately 
1 in 68 children. Early identification and intervention significantly improve the prognosis 
of children with ASDs. Research has demonstrated that screening and diagnosis of ASDs 
is reliable in children as young as 18 months. Cognitive impairment affects up to 70% of 
individuals with ASDs, and there is diagnostic overlap between ASDs and Intellectual 
Disability (ID). A subset of children with ASDs present with low mental ages (Low MA), 
defined as an age equivalent of below 12 months in all developmental domains, at the 
time of their first evaluation. While research has demonstrated that ASDs can be 
distinguished from ID diagnostically, the validity of utilizing ASD-specific screening and 
diagnostic tools in the presence of Low MA has not been investigated. In this study we 
investigated the diagnostic stability, developmental outcomes, and ASD symptomatology 
in a sample of children that were initially diagnosed with ASD Low-MA (n = 25), 
Autistic Disorder (AD; n = 111), and PDD-NOS (n = 82). The majority of children with 
ASD Low-MA (96%) remained on the autism spectrum at follow-up, compared to AD 
(86.5%) and PDD-NOS (73.2%). The ASD Low-MA group had the lowest mean ratio IQ 
scores and made the least developmental progress in all subdomains of the Mullen Early 
Scales of Development; the PDD-NOS had higher scores than the AD group in all 
domains. This trend was observed for the Vineland Adaptive Behavior Scales as well,  
with exceptions in the Domestic and Community domains; each group had comparable 
ratio IQ’s initially, but experienced a decrease in ratio IQ across time. The ASD Low-MA  
group had the highest total scores on the CARS, ADOS, and DSM-IV at both time points,  
indicating high and stable ASD symptom severity. The AD group demonstrated a higher 
rate of symptom improvement than the PDD-NOS and ASD Low-MA groups. These 
results suggest the validity of diagnosing ASDs in children that present with Low MA, as 
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Title: Autism Spectrum Disorders and Low Mental Age: Diagnostic Stability and 
Developmental Outcomes in Infants and Toddlers 
Introduction 
Autism Spectrum Disorders: Description, Diagnosis, and Intervention 
Autism Spectrum Disorders (ASDs) are characterized by behavioral deficits in 
social relatedness and communication, along with the presence of restricted interests 
and/or repetitive behaviors (RRBs). The autism spectrum includes several diagnoses that 
share these symptom clusters, such as Autistic Disorder (AD) and Pervasive 
Developmental Disorder – Not Otherwise Specified (PDD-NOS) (American Psychiatric 
Association, 2000). ASDs have received heightened attention among researchers and 
healthcare professionals primarily due to increasing rates of prevalence. In 2012, the 
Centers for Disease Control and Prevention estimated a rate of 1 in 88 children have an 
ASD (CDC, 2012), and by March 2014 this rate had increased to 1 in 68 (CDC, 2014). 
Caring for children with ASDs enacts a tremendous societal cost, with an estimated $9 
billion spent in the United States on healthcare and therapeutic, educational, and familial 
services in 2011 (Lavelle, Weinstein, Newhouse, Munir, Kuhlthau, & Prosser, 2014).  
Research has demonstrated that early identification and intervention are key in 
improving the prognosis of children with ASDs, and that intervention significantly lowers 
long-term societal costs (Chasson, Harris, & Neely, 2007). Instruments like Baron-
Cohen’s CHecklist for Autism in Toddlers (CHAT) (Baron-Cohen et al., 2000), Stone’s 
Screening Tool for Autism in Two-Year-Olds (STAT) (Stone, McMahon, & Henderson, 
2008), and the Modified Checklist for Autism in Toddlers (M-CHAT) (Robins et al., 
2001) screen for autism in children as young as 16 months. The use of these screening 
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tools allow for subsequent diagnosis and appropriate implementation of intervention 
services. Literature suggests that 25-40 hours per week is an optimal amount of 
intervention for children with an autism spectrum disorder (ASD) (Howard, Sparkman, 
Cohen, Green, & Stanislaw, 2005), and foundational studies assert the effectiveness of 
behaviorally-based interventions in increasing positive outcomes in young children with 
autism (Dawson et al., 2010; Green, Brennan, & Fein, 2002; McGee, Morrier, & Daly, 
1999).  
Autism Spectrum Disorders: Diagnostic Stability 
Research has demonstrated that the ASD diagnosis is reliable in children as young 
as 18 to 24 months (Charman et al., 2005; Moore & Goodson, 2003; Lord 1995). Filipek 
et al., in their 2000 review of screening and diagnostic practices for ASDs, cite several 
studies that found that difficulties with establishing eye contact, responding to name, 
establishing joint attention, engaging in pretend play and imitation, and delays in 
nonverbal communication and language are measurable by 18 months of age. This review 
also references retrospective studies that analyzed the home video tapes of children who 
had been diagnosed with a pervasive developmental disorder and/or ASD. Observers 
were able to distinguish children, some as young as eight months old, with an ASD from 
children with other developmental disabilities due to observed deficits in social and 
communicative skills, particularly joint attention (Mars, Mauk, & Dowrick, 1998) and a 
failure to orient toward name when it was called (Werner, Dawson, Osterling, & Dinno, 
2000).  
In addition to these observable, behavioral differences, several studies have 
established the stability of ASDs across time. Lord (1995) re-evaluated 16 children at age 
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three that had been diagnosed with an ASD at age two, finding that 14 of them continued 
to meet diagnostic criteria. Baron-Cohen et al. (1996) found that ten children diagnosed 
at 18-20 months all met criteria for ASD diagnoses at 40 months. Stone et al. (1999) 
followed a larger cohort of 65 children, 37 of whom were diagnosed with an ASD at 
around 30 months of age; a majority of these children continued to meet criteria for an 
ASD diagnosis in later childhood. Eaves and Ho (2004) re-evaluated 49 children at age 
four who had received a diagnosis of an ASD at age two, finding that 88% continued to 
meet criteria for an ASD. Charman et al. (2005) found that in a cohort of 26 children, 
ASD diagnosis based on standardized, autism-specific assessments at age three was 
highly consistent with diagnosis at age seven.  
More recently, Sutera et al. (2007) found that only 13 of 73 (18%) children 
originally diagnosed with an ASD at an initial evaluation no longer met the criteria for an 
ASD diagnosis at follow-up evaluation, while 60 the children (82%) retained an ASD 
diagnosis at re-evaluation. Kleinman et al. (2008) found that 15 of 77 children (19%) 
initially evaluated and diagnosed with ASD no longer met diagnostic criteria for an ASD 
at a follow-up evaluation. Using partly the same sample as the Kleinman et al. (2008) 
study, in a poster presentation Hinnebusch et al. (2012) assessed a larger sample of 132 
children diagnosed with an ASD at the initial evaluation, and found that upon 
reevaluation, 28 children (21%) no longer met diagnostic criteria for an ASD.  
Autism Spectrum Disorders: Intelligence and Low Mental Age 
Estimated rates of cognitive impairment in individuals with ASDs across the 
lifespan ranges from 24% (Chakrabarti & Fombonne, 2001), to as high as 70% 
(Fombonne, 2003). In Fombonne’s (2003) review of 32 epidemiological studies, 30% of 
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individuals with an ASD presented with mild to moderate cognitive impairment, while 
40% were severe to profoundly impaired. A recent prevalence study conducted by 
Charman et al. (2010) involving 75 children aged 10 to 14 with an ASD, demonstrated 
that 55% had an IQ below 70, 16% had an IQ below 50, 28% had an average intelligence 
(IQ between 85 and 115), and 3% had an IQ above 115. Within this sample, adaptive 
skill levels were significantly lower than IQ. However, intellectual ability varies heavily 
among individuals with ASDs, as well as among the different diagnoses that are included 
on the autism spectrum. Additionally, in recent decades the range of IQ in individuals 
with ASDs has expanded in tandem with increasing ASD prevalence, with this increase 
in prevalence attributed to improvements in identification and diagnostic practices, and a 
broadening of case definitions (Joseph, 2011).  
In previous years, the reliability of measuring IQ in children with ASDs had been 
scrutinized due to the social-communicative impairments and related behavioral issues 
common to ASDs that may confound the testing process (e.g., language delays, lack of 
imitative and reciprocal interactive skills, preoccupations or repetitive behaviors). 
Contemporary research has demonstrated, however, adequate predictability and stability 
of nonverbal intelligence in children with ASDs (Lord & Schopler, 1989a, 1989b; 
Sigman & Ruskin, 1999). In their 1989 study, Lord and Schopler demonstrated that 
among children with ASDs, IQ becomes more predictive as the minimum age at first 
assessment increases. In their sample, assessments of IQ at age two were not predictive of 
IQ at age seven (r = .00), but were predictive by age three (r = .52). These children also 
experienced sizeable changes in their absolute scores in intellectual ability across time; 
preschool children who initially scored in the mildly impaired range were as likely to 
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move into the unimpaired range (35%) as they were to remain in the impaired range 
(39%) at five year follow-up, and a portion of children in the severely impaired range 
moved into the mildly impaired range (38%). These findings have since been replicated 
in several studies (Sigman & Ruskin, 1999; Howlin, Goode, Hutton, & Rutter, 2004; 
Charman et al., 2005). Another study, conducted by Mayes and Calhoun (2003), assessed 
IQ data for 164 children with autism from age 3 to 15. They found that IQ increased with 
age; 67% of younger children in the sample demonstrated delayed speech abilities, while 
by school-age verbal and non-verbal IQs were no longer significantly different. It is 
essential to note, however, that the authors did not distinguish whether all of these 
children met criteria for an ASD (i.e., AD, PDD-NOS, etc.) or if by autism they were 
referring to the specific diagnosis of autistic disorder (AD).  
Lord (1995) demonstrated the reliability of assigning an ASD diagnosis to a group 
of cognitively typical, 18- to 24-month-old children, finding that clinical diagnosis was 
highly stable between initial diagnosis at age two and re-evaluation at age three. This 
study also demonstrated that diagnosis using formal measures changed significantly 
between initial and follow-up evaluations among children that were initially diagnosed 
with an ASD and were also significantly developmentally delayed. Lord implicated the 
emergence of identifiable repetitive behaviors in children with autism, and improvements 
in rudimentary social skills in the children judged not to be autistic as key factors that 
allow the differentiation of children with autism from developmentally delayed children. 
A significant amount of research regarding diagnosis, intervention efficacy, and outcome 
has been conducted in persons with ASDs with cognitively normal profiles (Hurley & 
Levitas, 2007).   
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However, a subgroup of children with ASDs present with a low mental age (Low-
MA), meaning the age equivalent at which a child is performing intellectually. For 
example, a child who receives an evaluation receives a standard score on a developmental 
measure, which allows comparison to the normative sample of children the same age who 
took this test. The raw score a child receives on an assessment can be converted to an age 
equivalent score, which allows a clinician to determine at what “age” the child is 
performing intellectually (e.g., a 2-year-old may be functioning at the level of an 18-
month-old in his/her expressive language). As stated previously, intellectual disability 
(ID), defined by having an IQ below 70, commonly co-occurs in children with ASDs at a 
rate of between 50-70% (Fombonne, 2003). The diagnosis of intellectual disability, 
however, is not assigned until age six; prior to age six, a child demonstrating clinically 
significant delays is typically diagnosed with Developmental Delay (DD) or Global 
Developmental Delay (GDD).  
There is a degree of diagnostic overlap between ASDs and ID: both are 
characterized by cognitive, adaptive, and social skill deficits, and often involve 
challenging and stereotyped behaviors (Matson & Shoemaker, 2009). Despite this, 
Osterling, Dawson, and Munson (2002) demonstrated that children who were later 
diagnosed with ASDs could be distinguished behaviorally from typically developing 
children and those with intellectual disabilities (IDs) by 12 months of age. They rated the 
social, communicative, and repetitive behaviors observed in home videos of infants, 
observing that children with ASDs looked at others less often and responded to their 
names less frequently than children with ID. Children with ID demonstrated a wide range 
of impairment across multiple developmental domains, while children with ASDs 
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demonstrated more severe deficits in communication. Other than the aforementioned 
studies, there is a paucity of literature regarding the reliability of an ASD diagnosis 
within the Low-MA subgroup. There is a lack of understanding of the diagnostic stability, 
symptomatology, and developmental profile of children with ASD and Low-MA, as well 
as how ASD-specific screening tools work within this sub-population.  
While research has demonstrated that ASDs can be distinguished from intellectual 
disability (Osterling, Dawson, & Munson, 2002), the validity of using common, ASD-
specific diagnostic tools in diagnosing autism in children with concurrent low mental age 
has not been demonstrated in the literature. For example, the Autism Diagnostic 
Interview-Revised (ADI-R) is only valid for children with a mental age above 24 months 
(Rutter, Le Couteur, Lord, & Faggioli, 2005). The Autism Diagnostic Observation 
Schedule (ADOS) has a Toddler module, which facilitates assessment in children as 
young as 12 months (Luyster et al., 2009), but not with mental ages below this point. 
However, other research claims that a more appropriate age of diagnosis is actually closer 
to 24 to 36 months, which would exclude all children with a low mental age, even if their 
chronological age were 24 to 36 months at time of evaluation. This calls into question the 
reliability of an early diagnosis of an ASD with co-occurring low mental age.  
Low mental age also influences the efficacy and validity of autism-specific 
screening tools. The M-CHAT (Robins et al., 2001) assesses for the presence of 
behaviors that Inada, Kamio, and Koyama (2010) demonstrated were typically present in 
normal development primarily after 12 months of age. If the M-CHAT were administered 
to the parents of a child with a mental age below 12 months, these behaviors would likely 
be absent and potentially affect the validity of such a screener. Similarly, Dietz et al. 
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(2006), in a study regarding the efficacy of the Early Screening of Autistic Traits 
Questionnaire (ESAT), which included 31,724 children aged 14 to 15 months, 
demonstrated a high false positive rate. Of the 73 children that failed the ESAT and 
received an evaluation, only 18 (25%) received a diagnosis of an ASD, while 13 (18%) 
received a diagnosis of mental retardation (intellectual disability), 18 (25%) a language 
disorder, and 11 (15%) another DSM-IV diagnosis. This is potentially suggestive of a 
similar effect observed by Inada et al. (2010) regarding the M-CHAT, which is that some 
typical children do not demonstrate these behavioral milestones until shortly after 14 
months of age. Matson and Shoemaker (2009) highlight a call for research that allows 
better understanding of the relationship and overlap between ID and ASD, citing a need 
for diagnostic instruments specific to co-occurring ID and ASD.  
ASD Symptom Severity and Developmental Progress: PDD-NOS and AD 
Under the DSM-IV-TR, the definition of AD inherently indicates a higher ASD 
symptom severity than PDD-NOS. To receive a diagnosis of AD a child must 
demonstrate deficits in Social and Communication abilities, as well as the presence of 
RRBs; PDD-NOS requires impairment in social interaction skills, and either impairment 
in communication or the presence of repetitive and stereotyped behaviors. As a result, 
some argue that PDD-NOS functions as an ambiguous and “catchall” diagnosis for 
children that do not fit the criteria of another developmental disorder, or who demonstrate 
some symptoms of autism, but also symptoms of other disorders (Filipek et al., 1999). 
More recently, new DSM-5 criteria have been adopted, which requires impairment in all 
three social-communication symptoms and two restricted/repetitive symptoms to qualify 
for an ASD diagnosis (American Psychiatric Association, 2013). It was designed on a 
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severity continuum, in which individuals with ASDs are rated from mild to severe 
according to their symptomatology, and the previous, individual diagnoses have been 
replaced with a single, overarching diagnostic category of Autism Spectrum Disorder. 
Previously, repetitive and restricted behavior patterns were not required to receive a 
diagnosis of PDD-NOS. Critics of the DSM-V criteria suggest that not only is there a loss 
in diagnostic nuance with the elimination of these single category diagnoses, but as many 
as 30% of children that would have previously received an ASD diagnosis by meeting 
criteria for the DSM-IV-TR’s PDD-NOS entry, would no longer receive a diagnosis 
under the DSM-V criteria (Barton et al., 2013; Jashar, 2014). 
Past studies have shown measurable differences in the cognitive, communication, 
and social relatedness skills between children with PDD-NOS and AD; children with 
PDD-NOS consistently measure at higher levels of ability and lower levels of impairment 
than children with AD (Cohen et al., 1986; Sevin et al., 1995). One such study (Bolte & 
Poustka, 2002) assessed the association between general cognitive level and adaptive 
behavior in 67 children with AD and PDD-NOS, utilizing the Vineland Adaptive Scales 
and the Wechsler Intelligence Scales. Across all participants, both in the AD and PDD-
NOS groups, intellectual functioning was measured at a higher level than adaptive 
behavior skills. However, among the higher functioning individuals (n = 34) with an IQ 
greater than 70, including both AD and PDD-NOS, IQ and adaptive behavior level 
differed significantly, while among the lower functioning individuals (n =33) with an IQ 
less than 70, adaptive behavior level was also low. These findings suggest that IQ 
mediates adaptive functioning; individuals of high intellectual ability have significantly 
lower adaptive skills, while individuals with lower intellectual ability have equally low 
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adaptive skills. The authors also observed that individuals with AD and PDD-NOS 
scored highest on Daily living, and lowest on Socialization, with Communication in 
between these. These authors grouped their participants by IQ, however, so differences in 
IQ and adaptive functioning by diagnosis (AD vs. PDD-NOS) were not explored.  
Several studies have demonstrated that children that received a diagnosis of PDD-
NOS had a higher likelihood of no longer demonstrating symptoms of an ASD at follow-
up, also referred to as “optimal outcome,” than children with AD (Lord et al., 2006, 
Sutera et al., 2007; Helt et al., 2008; Berry, 2009). Specifically, Berry (2009) 
demonstrated that among these children with PDD-NOS at an initial evaluation, those 
with higher motor ability early in development, low ASD symptom severity, lower levels 
of repetitive behaviors, and higher adaptive and expressive language abilities were more 
likely to move off the autism spectrum at follow-up. However, more recent studies have 
suggested that PDD-NOS as a diagnostic category is ambiguous and may involve several 
subtypes with distinct profiles (Paul et al., 2004; Walker et al. 2004). Brennan (2014) 
described three subsets of children with PDD-NOS: the first cluster included those 
children with few autism symptoms and high cognitive scores at initial evaluation, 60% 
of whom no longer met criteria for PDD-NOS at follow-up; the second cluster inlcuded 
those children with higher autism symptoms and lower cognitive scores at initial, 89.5% 
of whom met criteria for an ASD at follow-up; the third cluster included those children 
with the lowest cognitive scores and highest autism symptom severity (social and 




 Walker et al. (2004), in a study of 216 children with AD, and 21 with PDD-NOS, 
suggested that children with PDD-NOS demonstrate stronger cognitive and adaptive 
functioning and exhibited fewer repetitive and stereotyped behaviors than children with 
AD. Children in the PDD-NOS group received higher scores on the Communication, 
Social, and DLS subdomains than the AD group, and received lower scores on every 
domain of the ADI and ABC measuring severity of ASD symptoms. However, they also 
suggested that the PDD-NOS group could be divided into a high functioning group with 
mild symptoms of autism and mild cognitive delay (24%), a low functioning group that 
resembled AD with severe cognitive delays, but who had an onset of symptoms after 36 
months or had too few symptoms (< 6) to meet criteria for AD, and a final group (52%) 
lacking stereotyped and repetitive behaviors. The finding within this last subgroup is 
similar to the findings in other research studies, particularly in Mandy et al. (2011), 
which looked at a sample of 256 children with PDD-NOS, and found that only 3% of 
these children presented with repetitive or stereotyped behaviors (Buitelaar et al., 1999; 
Allen et al., 2001). These findings suggest that while there may be trends regarding ASD 
symptomatology within the PDD-NOS group, there is a relative degree of heterogeneity 
in their initial presentation and outcomes.  
Current Study 
At present, children are diagnosed with autism due to observed social and 
communicative deficits. Children that present with a Low MA may express similar core 
deficits, but not because they have an ASD, but because that child's mental age is lower 
than the age that these prosocial and communicative behaviors typically emerge. Autism 
and Low MA may in fact co-occur, but it is also a possibility that these behavioral 
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deficits are solely the result of a severe developmental delay. Studies that asses the 
diagnostic stability of children that receive an ASD diagnosis and also have Low MA are 
required to help demonstrate if an ASD diagnosis is reliable with accompanying Low 
MA.  
The current study aims to evaluate the diagnostic stability, symptomatology, and 
developmental profiles of children with ASDs and a Low-MA (ASD-Low MA). The 
Early Detection study has evaluated the effectiveness of the autism-specific screening 
instruments, the M-CHAT (Robins et al., 2001) and M-CHAT-R (Robins et al., 2014). 
Children that fail these screeners are offered an initial evaluation conducted when the 
child is between the ages of 18 and 30 months, which involves the administration of 
developmental and diagnostic measures, and provision of a diagnosis. Children are 
reassessed approximately two years later to assess current developmental functioning and 
diagnostic presentation. Children included in this sample received a diagnosis of Autistic 
Disorder (AD), Pervasive Developmental Disorder, Not Otherwise Specified (PDD-NOS), 
or ASD-Low MA at their initial evaluation and received a follow-up evaluation 
(diagnostic criteria for these disorders is specified in Methods). 
We predicted that some of the children who initially received an ASD diagnosis 
with a Low-MA would not retain the diagnosis at the follow-up evaluation. We 
hypothesized that a low mental age would cause the child to present with autism-like 
symptoms and delays in development. However, with the development of language and 
prosocial behavior between the initial and follow-up evaluations, these children might no 
longer express deficits consistent with an ASD diagnosis. If a child's developmental 
delays persisted, as would be expected, we predicted that they would then show more 
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classic intellectual disability, or developmental delay, without features of an ASD. 
Additionally, the gold standard diagnostic instruments, the Autism Diagnostic 
Observation Schedule (Lord et al., 1999) and the Autism Diagnostic Interview (Lord, 
Rutter & Le Couteur, 1994) are not designed to evaluate autism in children with mental 
ages below the age of about 18 months, which suggests that the validity of an ASD 
diagnosis in Low-MA children needs to be assessed. We planned to compare the ASD-
Low MA group’s performance on the M-CHAT and M-CHAT-R, diagnostic stability, 
and symptoms and developmental levels at both time points to the Autistic Disorder (AD) 
and Pervasive Developmental Disorder, Not Otherwise Specified (PDD-NOS) groups. 
While there is robust research assessing diagnostic stability in AD, PDD-NOS has 
received less attention, which will also be addressed in this study.  
There were several hypotheses for the current study:  
1. We predicted that a majority of children with an initial diagnosis of ASD-Low 
MA would no longer meet diagnostic criteria for an ASD, but continue to 
demonstrate significant developmental delay. We employed a qualitative, 
descriptive analysis of the 25 children in the ASD Low-MA group to evaluate this 
hypothesis.  
2. We predicted that children who received an initial diagnosis of AD or PDD-NOS 
would demonstrate a higher rate of diagnostic stability and likelihood of receiving 
an ASD diagnosis at follow-up than children who received an ASD-Low MA 
diagnosis. We also predicted that children who received an initial diagnosis of AD 
would have the highest diagnostic retention rate when compared to the PDD-NOS 
and ASD Low-MA groups.  
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a. We evaluated the differences in diagnostic stability among the AD (n = 
111), PDD-NOS (n = 82), and ASD Low-MA (n = 25) groups utilizing a 
series of chi-square analysis, comparing all three groups by: diagnostic 
outcome with all diagnostic possibilities included, diagnostic outcome 
differentiating ASD versus non-ASD diagnostic outcomes, and finally 
diagnostic outcome differentiated by retain original diagnosis, other ASD 
diagnosis, and other diagnosis. We compared two groups at a time if a 
significant difference was identified for each hypothesis. If the 
assumptions of the chi-square analysis were violated, we utilized a 
Fisher’s Exact Test to determine significant differences between groups.  
i. The sample size for the analysis including all diagnostic outcomes 
(N= 218) provided sufficient power (power= .80, alpha= .05) to 
detect an effect size of .27 (based on our chi-square design for 
degrees of freedom equal to 10, conventionally, phi of .07 is 
considered small, .21 medium, and .35 large), which is between 
medium and large (see Cohen, 1988). 
ii. The sample size for the analysis including ASD versus non-ASD 
diagnostic outcomes (N= 218) provided sufficient power 
(power= .80, alpha= .05) to detect an effect size of .19 (based on 
our chi-square design for degrees of freedom equal to 1, 
conventionally, phi of .10 is considered small, .30 medium, and .50 
large), which is between small and medium. 
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iii. The sample size for the analysis including retain original diagnosis, 
other ASD diagnosis, and other diagnosis study (N= 218) provided 
sufficient power (power= .80, alpha= .05) to detect an effect size 
of .21, which is between small and medium. 
3. We predicted that children who initially met criteria for ASD-Low MA would 
have lower developmental age-equivalents across all domains of functioning at 
both time points than children who initially met criteria for AD and PDD-NOS. 
Additionally, children with an initial diagnosis of ASD-Low MA would show 
significantly fewer developmental gains across time than children with AD and 
PDD-NOS. 
a. A series of univariate analysis of variance (ANOVA) were conducted to 
determine if there were differences between the AD, PDD-NOS, and ASD 
Low-MA groups in the amount of developmental gain made between the 
two evaluations in the following subdomains of the Mullen Early Scales of 
Learning: Visual Reception, Fine Motor, Receptive Language, and 
Expressive Language, and the following subdomains of the Vineland 
Adaptive Behavior Scales: Communication Domain: Expressive Language, 
Receptive Language; Daily Living Skills Domain: Personal, Domestic, 
Community, Interpersonal Relationships; Socialization Domain: Play and 
Leisure Time, and Coping Skills. This progress was measured by a ratio of 
change in age equivalent (mental age) divided by change in chronological 
age for each subdomain. If the overall effect of group on developmental 
progress was significant, post-hoc tests (LSD when equality of variances 
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is not violated, Games-Howell if it is violated) were conducted to specify 
the significance of the differences between each group.  
b. The power for the analyses regarding the Mullen varied slightly between 
subdomains due to missing data points. The Visual Reception and 
Receptive Language subdomains had sample sizes of N = 165, which 
provided sufficient power (power= .80, alpha= .05) to detect an effect size 
of .24. The Fine Motor subdomain had an overall sample size of N = 165, 
which provided sufficient power to detect an effect size of .24; Expressive 
Language had a sample size N = 163, which allowed enough power to 
detect an effect size of .25. The power for these analyses allowed for the 
detection of effect sizes that are between small and medium. 
c. The power for the analyses and effect size detection threshold regarding 
the Vineland are as follows: Expressive Language (N = 174), effect size 
of .24; Receptive Language (N = 174), effect size of .24; Personal (N = 
169), effect size of .24; Domestic (N = 128), effect size of .28; 
Community (N = 130), effect size of .28; Interpersonal Relationships (N = 
169), effect size of .24); Play and Leisure Time (N = 167), effect size 
of .24); Coping (N =119), effect size of .29. The power for these analyses 
allowed for the detection of effect sizes that are between small and 
medium. 
4. We predicted that children with an initial diagnosis of ASD-Low MA would show 
significantly fewer ASD symptoms at follow-up than children who initially met 
criteria for AD and PDD-NOS. We predicted that the AD group would 
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demonstrate the most symptoms of an ASD at both Time 1 and Time 2, and have 
the smallest rates of symptom change across time when compared to the PDD-
NOS and ASD Low-MA groups.  
a. A series of mixed model design analyses were conducted to investigate the 
relationship between initial diagnosis and ASD symptomatology at Time 1 
and Time 2 on the CARS, ADOS, and DSM-IV. If an interaction was 
present, a one-way ANOVA and post-hoc analyses (LSD or Games 
Howell) were performed to specify the significance of the differences 
between each group.  
b. The overall sample size for analyses regarding the CARS (N= 200) 
provided sufficient power (power= .80, alpha= .05) to detect an effect size 
of .22, which is between small and medium. The overall sample size for  
analyses regarding the ADOS (N= 175) provided sufficient power 
(power= .80, alpha= .05) to detect an effect size of .24, which is between 
small and medium. The overall sample size for analyses regarding the 
DSM-IV (N= 192) provided sufficient power (power= .80, alpha= .05) to 





Participants were recruited through the Early Detection study, which aims to 
assess the sensitivity and specificity of an ASD-specific screening questionnaire, the 
Modified Checklist for Autism in Toddlers (M-CHAT- Robins et al., 2001), and a revised 
version of the questionnaire, the M-CHAT-Revised (Robins, et al., 2014). Children were 
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enrolled in the study through two main referral sources: a pediatrician and an Early 
Intervention service provider. After enrollment, children received screening at an 18- or 
24-month well-child visit at with their pediatrician, or through screening with an Early 
Intervention staff member. The majority of study participants were residents of 
Connecticut, Massachusetts, and/or Rhode Island at the time of their enrollment, which 
resulted in mostly rural and suburban, and les urban, living situations represented among 
participants. Children were screened for significant sensory and motor impairment prior 
to the initial evaluation. Children with such impairments were excluded from the study 
due to the interference this would present in the administration and interpretation of the 
standardized measures used to development and adaptive skills. Data included in the 
current study represent the subsection of the total sample collected for the Early 
Detection study that received an initial diagnosis of AD, PDD-NOS, and ASD-Low MA.  
Diagnoses were based upon a child’s performance on the Mullen Scales of Early 
Learning (Mullen) (Mullen, 1994), the Vineland Adaptive Behavior Scales (Vineland) 
(Sparrow, Balla, & Cicchetti, 1984), the Autism Diagnostic Observation Schedule 
(ADOS) (Lord et al., 2000), and the Childhood Autism Rating Scale (CARS) (Schloper et 
al., 1980) (see below for descriptions). 
Diagnostic Criteria 
The diagnostic criteria for Autistic Disorder (AD) used in the study was consistent 
with the DSM-IV-TR definition (Appendix A, Appendix C). Children who received an 
AD diagnosis demonstrated impairment in all three ASD symptom domains 
(communication, socialization, and repetitive and restricted interests and behaviors) with 
a total of six or more symptoms at their initial evaluation, with symptom onset before the 
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age of three. Specifically, a child must have presented with at least two symptoms in the 
social cluster, one symptom in the communication cluster, and one symptom in the 
restricted interests and repetitive behaviors cluster. At least one of the child’s age 
equivalent scores on the Mullen Visual Reception, Receptive Language, and Expressive 
Language subscales must have been above 12 months. 
The diagnostic criteria for Pervasive Developmental Disorder, Not Otherwise 
Specified (PDD-NOS) used in the study was consistent with the DSM-IV-TR definition 
(Appendix A, Appendix C). To receive a diagnosis of PDD-NOS a child presented with 
one symptom in the social cluster, other than a failure to develop peer relationships 
appropriate to the child’s developmental level for initial evaluations only. The child also 
presented with at least one symptom in the communication cluster and/or one symptom in 
the repetitive and restricted interests and behaviors cluster. These children did not meet 
criteria for AD, Asperger’s Disorder, or Rett’s Syndrome, and their symptomatology 
could not have been better accounted for by another DSM-IV-TR disorder. At least one 
of the child’s age equivalent scores on the Mullen Visual Reception, Receptive Language, 
and Expressive Language subscales must have been above 12 months.  
Children that received an Autism Spectrum Disorder-Low MA diagnosis at the 
time of their evaluation presented with at least one symptom in the social cluster other 
than a failure to develop peer relationships appropriate to the child’s developmental level, 
at least one symptom from the communication cluster, and/or at least one symptom in the 
repetitive and restricted interests and behaviors cluster (Appendix C). Additionally, these 
children received age equivalent scores on the Mullen subscales of Visual Reception, 
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Receptive Language, and Expressive Language subscales that were all less than or equal 
to 12 months.  
To date, 219 children received an ASD diagnosis at their initial evaluation and 
later received a follow-up evaluation. Of these 219, 111 children received an initial 
diagnosis of AD, 83 received a diagnosis of PDD-NOS, and 25 received a diagnosis of 
ASD-Low MA through the study. For analyses, to assess for differences among these 
groups regarding all diagnostic outcomes, participants were coded into six categories 
based on their Time 2 diagnosis: Autistic Disorder, PDD-NOS, ASD Low-MA, 
Developmental Delay, Other Diagnosis, and No Diagnosis. Then, to better assess any 
significant differences found between the AD, PDD-NOS, and ASD Low-MA groups, 
participants were recoded based on whether their Time 2 diagnosis was an ASD (e.g., AD, 
PDD-NOS, or ASD Low-MA) or not (e.g., Developmental Delay, Other Diagnosis, No 
Diagnosis). Finally, participants from the AD, PDD-NOS, and ASD-Low MA groups 
were recoded into three groups: Retain Original Diagnosis, Other Autism Spectrum 
Disorder, and Other Diagnosis. Those participants in the Retain Original Diagnosis group 
received the same diagnosis at Time 2 as they did at Time 1. Those participants in the 
Other Autism Spectrum Disorder group received an ASD diagnosis at Time 2 that was 
different from their Time 1 diagnosis, but still on the autism spectrum. Those participants 
in the Other Diagnosis group received any other diagnostic outcome (e.g., Developmental 
Delay, Other Diagnosis, No Diagnosis).  
Demographic Information 
Demographic information for the children included in this study can be found in 
Table 1. The mean age of the children diagnosed with AD at their initial evaluation was 
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27.09 months (SD= 4.57 months) with a range of 17.74 months to 36.66 months. The 
mean age of the children diagnosed with PDD-NOS at their initial evaluation was 25.88 
months (SD= 4.04) with a range of 18.03 months to 34.43 months. The mean age of the 
children diagnosed with ASD Low-MA at their initial evaluation was 23.60 months (SD= 
4.50) with a range of 15.70 months to 31.80 months. A one-way multivariate analysis of 
variance (MANOVA) revealed a statistically significant difference in age based on a 
participant’s initial diagnosis, F (4, 428) = 3.67, p < .006; Wilk's Λ = 0.935, partial 
η2 = .033. A Least Significant Difference (LSD) post-hoc analysis revealed significant 
differences in Time 1 age between the AD and ASD-Low MA (p < .0005) and the PDD-
NOS and ASD-Low MA (p = .023), but not the AD and PDD-NOS groups (p = .058). 
The mean age of the children diagnosed with AD at their follow-up evaluation was 53.27 
months (SD= 9.41 months) with a range of 41.38 months to 113.48 months. The mean 
age of the children diagnosed with PDD-NOS at their follow-up evaluation was 51.49 
months (SD= 10.38) with a range of 38.12 months to 106.52 months. The mean age of 
the children diagnosed with ASD Low-MA at their follow-up evaluation was 49.37 
months (SD= 6.48) with a range of 34.36 months to 62.13 months. A Least Significant 
Difference (LSD) post-hoc analysis revealed no significant differences in Time 2 age 
between the AD and ASD-Low MA (p = .066), the PDD-NOS and ASD-Low MA (p 
= .33), and the AD and PDD-NOS groups (p = .2).  
Of the AD participants, 93 were male (83.8%) and 18 were female (16.2%). Of 
the PDD-NOS participants, 65 were male (78.3%) and 18 were female (21.7%). Of the 
ASD Low-MA participants, 20 were male (80%) and 5 were female (20%). There were 
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no significant differences in gender between the AD, PDD-NOS, and ASD Low-MA 
groups, x2 (2, N = 219) = .964, p = .617.  
Child ethnicity was collected through parent report using the following categories: 
White/European American, Hispanic/Latino- not Puerto Rican, Puerto Rican, African 
American, Caribbean or Caribbean American, Asian or Asian American, Native 
Hawaiian or Pacific Islander, Native American Indian, or Other. Participant responses 
were recoded into 5 categories: White/Caucasian, African American, Hispanic/Latino, 
Asian, Biracial. Of the AD participants, ethnicity information was available for 106 
children. 87 (82.1%) of these children were White/European American, 2 (1.9%) children 
were African American, 9 (8.5%) children were Hispanic/Latino, 4 (3.8%) were Asian, 
and 4 (3.8%) were biracial. Ethnicity information was available for 79 PDD-NOS 
participants; 67 (84.8%) of these children were White/European American, 4 (5.1%) 
children were African American, 5 (6.3%) children were Hispanic/Latino, and 3 (3.8%) 
were Asian. Ethnicity information was available for all 25 ASD Low MA participants; 19 
(76%) of these children were White/European American, 2 (8%) children were African 
American, 3 (12%) children were Hispanic/Latino, and 1 (4%) were biracial. Chi-square 
tests revealed no significant differences in ethnicity between the AD, PDD-NOS, and 
ASD Low MA groups, x2 (8, N = 210) = 7.450, p = .490, however this result violated the 
assumptions of the chi-square test because 10 of the cells (66.7%) had an expected count 
that was less than five. Fisher’s exact test revealed that the AD, PDD-NOS, and ASD 
Low MA groups were not significantly different in ethnicity, (p =.365).  
Maternal education was self-reported in the following categories: no degree or 
diploma, high school diploma/GED, vocational or technical degree, Associate’s Degree, 
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Bachelor’s Degree, Master’s degree, and Graduate or Professional Degree (M.D., J.D., or 
Ph.D.). Maternal education information was available for 154 of the participants, in both 
the AD (n = 70), PDD-NOS (n = 65), and ASD Low-MA (n = 19) groups. The modal 
level of maternal education for the entire sample was High School Diploma/GED; the 
median level was Associates Degree. Chi-square tests did not reveal significant 
differences between the maternal education of the AD, PDD-NOS, and ASD Low-MA 
groups, x2 (12, N = 154) = 9.6746, p = .645, though this result violated the assumptions of 
the chi-square test as 11 of the cells (52.4%) had an expected count that was less than five. 
Fisher’s exact test revealed that the AD, PDD-NOS, and ASD Low MA groups were not 
significantly different in maternal education, (p =.814). For analyses, maternal education 
was recoded as an ordinal variable, with a number (1-7) assigned to each tier in ascending 
order. 
Family income was determined through self-report by indication of annual 
household income. Annual household income was stratified in $10,000 intervals, ranging 
from between less than $10,000 to greater than $100,000 (i.e., $10,000-20,000, $20,000-
30,000, etc.). Family income information was available for 143 participants, in the AD (n 
= 63), PDD-NOS (n = 63), and ASD Low MA (n = 17) groups. Parents of the entire 
sample represented the full range of yearly incomes, the modal annual income was 
$10,000-20,000, and the median annual income for the entire sample was $50,000-60,000. 
Chi-square tests revealed no significant differences between the AD, PDD-NOS, and 
ASD Low-MA groups, x2 (20, N = 143) = 23.166, p = .281, though the assumptions of 
this test were violated, as 17 of the cells (51.5%) had expected counts that were less than 
five. A Fisher’s Exact Test, utilizing 2-sided Monte Carlo standards due to a high number 
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of data points, revealed no significant differences between groups (p = .332; lower bound 
= .328, upper bound = .336) based on 100,000 sampled tables. For analyses, family 
income was coded as an ordinal variable, with a number (1-11) assigned to each income 
tier in ascending order. 
Measures 
 ASD screening and diagnostic measures and developmental level 
Children received measures assessing developmental level and adaptive skills as 
part of a standardized battery. Study personnel administered measures to assess ASD 
symptomatology, including the Autism Diagnostic Observation Schedule, the Autism 
Diagnostic Interview, Revised, and the Childhood Autism Rating Scale (Lord, Risi, 
Lambrecht, Cook, Leventhal & DiLavore et al., 2000; Schopler, Reichler, & Renner, 
1988; Rutter, Le Couteur, &Lord, 2003). The Modified Checklist for Autism in Toddlers 
was used to screen for ASD, and has demonstrated exceptional psychometric properties 
(Kleinman, Robins, Ventola, Pandey, 2008; Robins, Fein, Barton, Green, 2001).  
Modified Checklist for Autism in Toddlers (M-CHAT) (Robins et al., 2001) 
 The Modified Checklist for Autism in Toddlers (M-CHAT) is a tool that screens 
for behaviors in children consistent with those observed in children with an ASD. The M-
CHAT is a 23-item questionnaire in which parents respond “yes” or “no” answer to 
questions regarding their child’s behavior (Robins et al., 2001). The measure was 
developed from the Checklist for Autism in Toddlers, which identifies children aged 18 
months who are at risk for autism (CHAT- Baron-Cohen, Allen, & Gillberg, 1992; 
Baron-Cohen, Cox, & Baird, 1996). Of the questionnaire’s 23 items, four are reverse-
scored; for a typically developing child a parent would most likely answer “no,” reducing 
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response bias (e.g., “Does your child ever seem oversensitive to noise?”). If a child fails 
three out of 23 total items, or two out of six “critical items,” it is considered screening 
positive on the M-CHAT. If a child screens positive, their caregivers receive a follow-up 
phone screening, in which failed items are re-assessed, in more detail. If a child continues 
to fail the M-CHAT after phone screening, they qualify for a free initial developmental 
evaluation, and a subsequent follow-up evaluation two years afterward. The M-CHAT’s 
internal reliability was demonstrated to be adequate for the 23-item checklist (α = .85), as 
well as six “critical items” (α = .83), in both the original study sample (Robins et al., 
2001) and in an additional study (α = .85, α = .83; Kleinman et al., 2008). The majority of 
children included in the sample for this study were screened using the M-CHAT (n = 
196); 100 from the AD group, 74 from the PDD-NOS group, and 22 from the ASD Low-
MA group.  
Modified Checklist for Autism in Toddlers-Revised (M-CHAT-R) (Robins et al., 2014) 
The M-CHAT-R is the current measure used in the Early Detection Study, 
composed of 20 yes/no parent-report items that were reworded to improve 
comprehension. Additionally, the order of items was revised to counteract a tendency of 
parents to endorse “yes” for all items, examples were provided to increase the clarity of 
items, and three low-performing M-CHAT items were removed. As with the M-CHAT, 
children who screened positive (failing two of seven “best 7” items, or any three items) 
on the M-CHAT-R were given a follow-up phone interview. Children that continued to 
screen positive on the M-CHAT-R on the phone interview were offered free diagnostic 
evaluations. Published findings show that the M-CHAT-R is an effective screening tool 
when used in a low-risk, pediatric sample (with a cut-off of two failed items, sensitivity 
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= .94, specificity = .83). Eleven children from the AD group, nine from the PDD-NOS, 
and three from the ASD Low-MA group included in the sample for this study were 
screened using the M-CHAT-R.  
Mullen Scales of Early Learning 
The Mullen Scales of Early Learning (Mullen, 1994) is a standardized test of 
cognitive ability, intended to evaluate children between birth and age 68 months. Of its 
five subtests, Gross Motor, Visual Reception, Fine Motor, Expressive Language, and 
Receptive Language, all but the Gross Motor scale were administered in this study. The 
Early Learning Composite (ELC) is a score that is considered an overall estimate of a 
child’s developmental age, and is generated by summing a child’s performance across all 
four domains administered in this study. In each subtest, T-scores, percentile ranks, and 
age equivalents are produced, which reflect the child’s current level of development in 
comparison to same-aged peers. The Mullen was normed on a nationally representative 
sample of 1,849 children (48.7% female, 51.3% male). It is a frequently used measure of 
developmental level and cognitive functioning in both typically developing children and 
children with developmental delays, and has demonstrated good reliability and validity. 
The Mullen demonstrates satisfactory internal consistency of .75 to .83. The test re-test 
reliability of the Mullen is .84 for younger children, and .76 for older children (Mullen, 
1994). 
For analyses, Time 1 age equivalent scores for each tested subdomain of the 
Mullen were subtracted from Time 2 age equivalent scores. This difference can be 
considered the amount of developmental progress, in months, made between Time 1 and 
Time 2. A positive difference indicates that a child made developmental gains within an 
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area between evaluations, a difference of zero would indicate no developmental gains, 
and a negative difference would indicate a lower developmental level at Time 2 
compared to Time 1. The number of months between the Time 1 and Time 2 evaluations 
was calculated for each child.  
The ratio estimate used in these analyses to assess developmental progress 
between evaluations (mental age divided by chronological age) was based upon a ratio 
used in a research study evaluating developmental progress in children with ASDs, and is 
common to outcome literature where standardized scores have restricted range (Sallows 
& Graupner, 2005). For example, for each child, the difference between Time 2 and Time 
1 age equivalent scores from the Expressive Language subtest was divided by the number 
of months that passed between Time 1 and Time 2 for each specific child. This quotient 
represents the change in mental age, or the proportion of expected developmental gain 
over the actual time elapsed between evaluations. For example, if a child demonstrated 2 
years of developmental gain as measured by the Mullen and 2 chronological years had 
elapsed between evaluations, this ratio is equal to 1. A similar quotient was generated for 
the Visual Reception, Fine Motor, and Receptive Language subdomains. In summary: a 
quotient greater than 1 indicates developmental progress in months greater than the 
amount of chronological time that had passed; a quotient equal to 1 indicates the same 
amount of developmental progress in months as the number of actual months that had 
passed; a quotient less than 1 indicates less developmental progress in months than the 
actual number of months that had passed.  
Additionally, a ratio IQ estimate, which is commonly utilized in statistical 
analysis for studies involving participants with low mental ages/intelligence quotients 
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(Kanne, et al., 2011), was generated for each participant. This IQ estimate was generated 
for each of the Mullen subdomains, at both time points, and was equal to the quotient of 
mental age (represented by age equivalent score) divided by chronological age, 
multiplied by 100. This allows for more sensitive comparison of data than utilizing the T-
scores of the Mullen, which are affected by a floor effect due to the low mental age and 
level of development of the participants across groups. 
Vineland Adaptive Behavior Scales- Interview Edition 
 
The Vineland Adaptive Behavior Scales (Sparrow, Balla, & Cicchetti, 1984) is a 
standardized parent report interview that assesses a child’s adaptive skills. It includes the 
domains of Communication, Daily Living, Socialization, and Motor Skills. The measure 
yields domain scores, standard scores for individual subscales, and an overall Adaptive 
Behavior Composite (ABC), which allows for comparison to a child’s skills to same-aged 
peers. The Vineland has established reliability and validity (Sparrow, Balla, &Cicchetti, 
1984) and it is frequently used with varied clinical populations. The Vineland is 
considered valid and commonly used in the assessment of children with developmental 
delays and ASDs, in both research and clinical applications (Klin, Carter, & Sparrow, 
1997). For the range of ages included in the Early Detection sample, the Vineland 
demonstrates high internal consistency for its adaptive behavioral composite (.90) and 
domain scores (.80-.90). Test-retest reliability for the subdomains was adequate (ICC 
of .85 and higher), and inter-rater reliability for the adaptive composite score (.87) and 
domain scores (.75) were acceptable (Sparrow, Cicchetti, Balla 2005). 
For analyses, the same method (Sallows & Graupner, 2005) to calculate a 
progress value for the Mullen subdomains (i.e., change in mental age, or age equivalent 
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score, in each subdomain divided by change in chronological age between Time 1 and 
Time 2) was utilized to create a progress value for the Vineland subdomains. Likewise, 
the same method to calculate a ratio IQ for the Mullen subdomains (the quotient of 
mental age divided by chronological age, multiplied by 100) was utilized to create a ratio 
IQ for the Vineland subdomains.  
Autism Diagnostic Observation Schedule 
The Autism Diagnostic Observation Schedule - Generic (ADOS) (Lord et al., 
2000) is a semi-structured assessment designed to measure potential ASDs. Only 
behaviors viewed during test administration are scored on this measure. The ADOS-G 
includes four modules, one of which is administered depending on the child’s expressive 
language level and chronological age. The current study used modules one and two 
during the initial evaluations (Time 1 and 2). For analyses, an ADOS calibrated severity 
score (CSS) was calculated for Time 1 and Time 2 according to the algorithms developed 
by Gotham, Pickles, & Lord (2008). 
Childhood Autism Rating Scale 
The Childhood Autism Rating Scale (CARS) (Schopler et al., 1980) is a behavior 
rating scale that consists of 15 subscales for rating aspects of autistic behavior. The scale 
is based on a clinician’s direct observation of the child and parent report of behaviors. 
The scale yields a numerical score of ASD symptom severity. The score can be used to 
label a child’s symptoms as non-autistic, mild, moderate, and severe. The CARS total 
score was used in analyses.  
DSM-IV Summary Sheet 
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A summary sheet generated by the clinicians on the Early Detection Study, based 
on the official DSM-IV-TR criteria for ASDs, was completed for each participant at Time 
1 and Time 2 (Appendix C). Participants received score of 1 for each symptom of an 
ASD they exhibited at the time of their evaluation. Symptoms were grouped into three 
sub-domains: Social, Communication, and Repetitive and Restricted Behaviors. The sum 
of all sub-domains is considered the Total score for this summary sheet. The total scores 
for the three sub-domains, as well as the Total score for the summary sheet, was utilized 
in analyses.  
Procedures 
When the child was between 16 and 30 months, their parent or caregiver 
completed the M-CHAT or the M-CHAT-R through the pediatrician’s office or Early 
Intervention provider (Robins et al., 2001). If a child failed the M-CHAT or M-CHAT-R, 
their parents received a follow-up interview over the phone. Upon phone follow-up, if the 
child continued to fail, the family was offered a free developmental evaluation at the 
University of Connecticut. This evaluation was conducted by a licensed psychologist or a 
developmental pediatrician, and a graduate student. Participants lacking transportation 
were provided a free taxi service from their homes to the study. In some cases, study staff 
traveled to conduct evaluations at participating pediatric offices in two large towns with a 
high proportion of low SES families. The diagnosis of AD, PDD-NOS, and ASD Low-
MA was made based on meeting cut-off scores on ADOS and CARS, as well as the 
Mullen and Vineland, derived by the clinicians on the Early Detection study (Appendix 
C). This first evaluation will be referred to as the initial evaluation, or Time 1.  
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Children became eligible to receive a follow-up evaluation, at Time 2, when they 
were 42 months or older, and were invited back to the University of Connecticut. This 
follow-up evaluation included the same measures assessing developmental and adaptive 
skills as at Time 1, and a diagnosis was made based on meeting cut-off scores on the 
ADOS and CARS, and the Mullen and the Vineland.  
All of the children in this study, in the AD, PDD-NOS, and ASD-Low MA groups, 
failed (screened positive on) the M-CHAT or M-CHAT-R, as well as the phone interview, 
and received an initial and follow-up evaluation.  
Results 
Diagnostic Stability of AD, PDD-NOS and ASD Low-MA: All Diagnostic Outcomes 
A chi-square analysis was conducted to compare possible differences in the 
diagnostic stability of the AD (N = 111), PDD-NOS (N = 83), and ASD Low-MA (N = 
25) groups, when considering every possible diagnostic outcome. A Time 1 diagnosis 
was missing for one child in the PDD-NOS group, so that participant was not included in 
these analyses.  
The Time 2 diagnostic outcomes for the 111 children that received a diagnosis of 
AD at Time 1 are as follows: AD, n = 75 (67.6%); PDD-NOS, n = 21 (18.9%); ASD 
Low-MA, n = 0; Developmental Delay, n = 2 (1.8%); Other Diagnosis, n = 1 (.9%); No 
Diagnosis, n = 12 (10.8%). The Time 2 diagnostic outcomes for the 82 children that 
received a diagnosis of PDD-NOS at Time 1 are as follows: AD, n = 28 (34.1%); PDD-
NOS, n = 32 (39%); ASD Low-MA, n = 0; Developmental Delay, n = 9 (11%); Other 
Diagnosis, n = 3 (3.7%); No Diagnosis, n = 10 (12.2%). The Time 2 diagnostic outcomes 
for the 25 children that received a diagnosis of ASD Low-MA at Time 1 are as follows: 
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AD, n = 18 (72%); PDD-NOS, n = 1 (4%); ASD Low-MA, n = 5 (20%); Developmental 
Delay, n = 1 (1.4%); Other Diagnosis, n = 0; No Diagnosis, n = 0 at Time 2 (Table 2). 
This initial chi-square analysis revealed that there was an overall difference in the 
diagnostic stability based on Time 1 diagnosis of either AD, PDD-NOS, and ASD Low-
MA, x2 (10, N = 218) = 74.83, p = >.0005, Phi = .586. The assumptions of this chi-square 
analysis were violated, as nine of the cells had expected counts that were less than five. 
Fisher’s Exact Test (Monte Carlo Significance, 2-sided) was significant for differences 
between groups (p <.0005) based on 100,000 sampled tables.  
Diagnostic Stability: ASD vs. Non-ASD Time 2 Diagnosis 
Of the 111 children that received an AD diagnosis at Time 1, 96 (86.5%) received 
an ASD diagnosis, while 15 (13.5%) received a non-ASD diagnosis. Of the 82 children 
that received a PDD-NOS diagnosis at Time 1, 60 (73.2%) received an ASD diagnosis, 
while 22 (26.8%) received a non-ASD diagnosis. Of the 25 children that received an 
ASD Low-MA diagnosis at Time 1, 24 (96%) received an ASD diagnosis, while 1 (4%) 
received a non-ASD diagnosis. Chi-square analysis revealed a significant difference 
between the AD, PDD-NOS, and ASD Low-MA groups in their likelihood to remain on 
the autism spectrum at Time 2, x2(2, N = 218) = 9.35 , p = .009, Phi = .207 (Table 3).   
Follow-up chi-square analyses were then conducted to specify the significant 
differences between these groups by individually comparing the AD and PDD-NOS, the 
AD and ASD Low-MA, and the PDD-NOS and ASD Low-MA groups on whether they 
retain an ASD diagnosis or receive a non-ASD diagnosis at Time 2. The AD and PDD-
NOS groups were significantly different, as participants from the AD group (86.5%) were 
more likely to receive an ASD diagnosis at Time 2 than those in the PDD-NOS group 
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(73.2%), x2(1, N = 193) = 5.39 , p = .026, Phi = .167. The AD and ASD Low-MA groups 
were not significantly different, as participants from the AD group (86.5%) and ASD 
Low-MA (96%) had a similar likelihood of receiving an ASD diagnosis at Time 2, x2(1, 
N = 136) = 1.78 , p = .304, Phi = -.114. The PDD-NOS and ASD Low-MA groups were 
significantly different, as participants from the ASD Low-MA group (96%) were more 
likely to receive an ASD diagnosis at Time 2 than those in the PDD-NOS group (73.2%), 
x2(1, N = 107) = 5.92 , p = .013, Phi = -.235.  
Diagnostic Stability: Retain Original Diagnosis, Other ASD, Other Diagnosis 
Of the 111 children in the AD group, 75 (67.6%) retained that diagnosis, 21 
(18.9%) received another ASD diagnosis, and 15 (13.5%) received another diagnosis at 
Time 2. Of the 82 children in the PDD-NOS group, 32 (39%) retained that diagnosis, 28 
(34.1%) received another ASD diagnosis, and 22 (26.8%) received another diagnosis at 
Time 2. Of the 25 children in the ASD Low-MA group, 5 (20%) retained that diagnosis, 
19 (76%) received another ASD diagnosis, and 1 (4%) received another diagnosis at 
Time 2. Chi-square analysis revealed a significant difference between the AD, PDD-NOS, 
and ASD Low-MA groups in their likelihood to retain their initial diagnosis, receive a 
different autism spectrum diagnosis, and receive another diagnosis at Time 2, x2(4, N = 
218) = 42.29 , p = >.0005, Phi = .440 (Table 4).  
Follow-up chi-square analyses were then conducted to specify the significant 
differences between these groups by individually comparing the AD and PDD-NOS, the 
AD and ASD Low-MA, and the PDD-NOS and ASD Low-MA groups on whether they 
retained their Time 1 diagnosis, received another ASD diagnosis, or receive another 
diagnosis at Time 2. The AD and PDD-NOS groups were significantly different, as 
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participants from the AD group (67.6%) were more likely to retain their Time 1 diagnosis 
than those in the PDD-NOS group (39%), x2(2, N = 193) = 15.59 , p < .0005, Phi = .284. 
The AD and ASD Low-MA groups were significantly different, as participants from the 
AD group (67.6%) were more likely to retain their Time 1 diagnosis than those in the 
ASD Low-MA group (20%) at Time 2, x2(2, N = 136) = 32.02 , p < .0005, Phi = .485. 
The PDD-NOS and ASD Low-MA groups were significantly different, as participants 
from the ASD Low-MA group (76%) were more likely to receive an ASD diagnosis at 
Time 2 than those in the PDD-NOS group (34.1%), x2(2, N = 107) = 14.291 , p = .001, 
Phi = .365.  
Developmental Progress by Diagnosis – Mullen (AD, PDD-NOS, ASD Low-MA): 
 
Visual Reception 
Time 1 and Time 2 Visual Reception data were available for 80 children from the 
AD group, 66 children from the PDD-NOS group, and 19 children from the ASD Low-
MA group. At Time 1, the mean Visual Reception ratio IQ for the AD group was 66.81 
(SD = 19.86), PDD-NOS was 73.33 (SD = 17.09), and ASD Low-MA was 40.28 (SD = 
12.08). At Time 2, the mean Visual Reception ratio IQ for the AD group was 74.26 (SD 
= 28.68), PDD-NOS was 85.92 (SD = 27.74), and ASD Low-MA was 41.72 (SD = 
20.32) (Table 5). A mixed model design analysis did not demonstrate a significant 
interaction between Time 1 diagnosis and time-point (Time 1 and Time 2), F(2, 162) = 
1.655, p = 1.94.  
The mean mental growth rates for Visual Reception, which were .86 (SD = .59) 
for the AD group, .99 (SD = .51) for the PDD-NOS group, and .48 (SD = .43) for the 
ASD Low-MA group, were significantly different by group, F(1, 162) = 6.69, p = .002. A 
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post-hoc LSD analysis revealed significant differences in VR progress between the AD 
and ASD-Low MA (p = .007) and the PDD-NOS and ASD-Low MA (p < .0005) groups, 
but not the AD and PDD-NOS groups (p = .129) (Table 6).  
Fine Motor 
Time 1 and Time 2 Fine Motor data were available for 78 children from the AD 
group, 66 children from the PDD-NOS group, and 20 children from the ASD Low-MA 
group. At Time 1, the mean Fine Motor ratio IQ for the AD group was 73.81 (SD = 
26.36), PDD-NOS was 76.74 (SD = 13.99), and ASD Low-MA was 56.73 (SD = 14.00). 
At Time 2, the mean Fine Motor ratio IQ for the AD group was 70.37 (SD = 22.82), 
PDD-NOS was 75.61 (SD = 20.89), and ASD Low-MA was 39.75 (SD = 13.05) (Table 
5). A mixed model design analysis demonstrated a significant interaction between Time 1 
diagnosis and time-point (Time 1 and Time 2), F(2, 161) = 3.831, p =.024. 
The mean mental growth rates for Fine Motor, which were .69 (SD = .43) for the 
AD group, .74 (SD = .41) for the PDD-NOS group, and .27 (SD = .24) for the ASD Low-
MA group, were significantly different by group, F(1, 161) = 10.73, p < .0005. Levene’s 
test for equality of variances was found to be violated for the present analysis, F(2,161) = 
3.28, p = .04. Due to this, a Games-Howell post-hoc analysis was conducted in lieu of an 
LSD analysis, which revealed significant differences in FM progress between the AD and 
ASD-Low MA (p < .0005) and the PDD-NOS and ASD-Low MA (p < .0005), but not the 
AD and PDD-NOS groups (p = .74) (Table 6).  
Receptive Language 
Time 1 and Time 2 Receptive Language data were available for 79 children from 
the AD group, 66 children from the PDD-NOS group, and 20 children from the ASD 
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Low-MA group. At Time 1, the mean Receptive Language ratio IQ for the AD group was 
43.78 (SD = 23.25), PDD-NOS was 54.55 (SD = 22.15), and ASD Low-MA was 30.00 
(SD = 16.14). At Time 2, the mean Receptive Language ratio IQ for the AD group was 
63.10 (SD = 28.62), PDD-NOS was 77.01 (SD = 29.05), and ASD Low-MA was 32.05 
(SD = 17.93) (Table 5). A mixed model design analysis demonstrated a significant 
interaction between Time 1 diagnosis and time-point (Time 1 and Time 2), F(2, 162) = 
3.988, p =.02.  
The mean mental growth rates for Receptive Language, which were .88 (SD 
= .60) for the AD group, .99 (SD = .51) for the PDD-NOS group, and .34 (SD = .34) for 
the ASD Low-MA group, were significantly different by group, F(1, 162) = 11.37, p  
<.0005. Levene’s test for equality of variances was found to be violated for the present 
analysis, F(2,162) = 4.31, p = .015. A Games-Howell post-hoc analysis revealed 
significant differences in RL progress between the AD and ASD-Low MA (p < .0005) 
and the PDD-NOS and ASD-Low MA (p < .0005), but not the AD and PDD-NOS groups 
(p = .467) (Table 6).  
Expressive Language 
Time 1 and Time 2 Expressive Language data were available for 79 children from 
the AD group, 65 children from the PDD-NOS group, and 19 children from the ASD 
Low-MA group. At Time 1, the mean Expressive Language ratio IQ for the AD group 
was 48.11 (SD = 23.09), PDD-NOS was 58.34 (SD = 18.64), and ASD Low-MA was 
33.55 (SD = 12.98). At Time 2, the mean Expressive Language ratio IQ for the AD group 
was 60.63 (SD = 26.67), PDD-NOS was 71.87 (SD = 24.72), and ASD Low-MA was 
33.49 (SD = 20.36) (Table 5). A mixed model design analysis did not demonstrate a 
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significant interaction between Time 1 diagnosis and time-point (Time 1 and Time 2), 
F(2, 160) = 2.34, p =.094. 
The mean mental growth rates for Expressive Language, which were .77 (SD 
= .52) for the AD group, .85 (SD = .47) for the PDD-NOS group, and .35 (SD = .34) for 
the ASD Low-MA group, were significantly different by group, F(1, 160) = 8.26, p 
< .0005. A post-hoc LSD analysis revealed significant differences in EL progress 
between the AD and ASD-Low MA (p = .001) and the PDD-NOS and ASD-Low MA (p 
< .0005), but not the AD and PDD-NOS groups (p = .33) (Table 6).  
Developmental Progress by Diagnosis – Vineland (AD, PDD-NOS, ASD Low-MA): 
Communication: Expressive and Receptive Language 
Time 1 and Time 2 Expressive Language data were available for 83 children from 
the AD group, 72 children from the PDD-NOS group, and 19 children from the ASD 
Low-MA group. At Time 1, the mean Expressive Language ratio IQ for the AD group 
was 38.33 (SD = 18.22), PDD-NOS was 49.37 (SD = 16.72), and ASD Low-MA was 
32.27 (SD = 12.07). At Time 2, the mean Expressive Language ratio IQ for the AD group 
was 57.67 (SD = 60.49), PDD-NOS was 62.50 (SD = 26.52), and ASD Low-MA was 
28.47 (SD = 13.39) (Table 7). A mixed model design analysis did not demonstrate a 
significant interaction between Time 1 diagnosis and time-point (Time 1 and Time 2), 
F(2, 171) = 2.18, p =.116. 
The mean mental growth rates for Expressive Language, which were .80 (SD = 
1.32) for the AD group, .76 (SD = .48) for the PDD-NOS group, and .24 (SD = .98) for 
the ASD Low-MA group, were not significantly different by group, F(1, 171) = 2.63, p 
= .075. However, a post-hoc LSD analysis revealed significant differences in EL progress 
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between the AD and ASD-Low MA (p = .026) and the PDD-NOS and ASD-Low MA (p 
= .04), but not the AD and PDD-NOS groups (p = .82) (Table 8).  
Time 1 and Time 2 Receptive Language data were available for 83 children from 
the AD group, 72 children from the PDD-NOS group, and 19 children from the ASD 
Low-MA group. At Time 1, the mean Receptive Language ratio IQ for the AD group was 
44.27 (SD = 22.13), PDD-NOS was 56.73 (SD = 23.09), and ASD Low-MA was 33.11 
(SD = 13.30). At Time 2, the mean Receptive Language ratio IQ for the AD group was 
60.39 (SD = 31.53), PDD-NOS was 72.39 (SD = 33.92), and ASD Low-MA was 36.50 
(SD = 24.74) (Table 7). A mixed model design analysis did not demonstrate a significant 
interaction between Time 1 diagnosis and time-point (Time 1 and Time 2), F(2, 171) = 
1.26, p =.286. 
The mean mental growth rates for Receptive Language, which were .77 (SD 
= .62) for the AD group, .91 (SD = .7) for the PDD-NOS group, and .41 (SD = .47) for 
the ASD Low-MA group, were significantly different by group, F(1, 171) = 4.78, p = .01. 
A post-hoc LSD analysis revealed significant differences in RL progress between the AD 
and ASD-Low MA (p = .026) and the PDD-NOS and ASD-Low MA (p = .002), but not 
the AD and PDD-NOS groups (p = .18) (Table 8). 
Daily Living Skills: Personal, Domestic, Community 
Time 1 and Time 2 Personal data were available for 81 children from the AD 
group, 70 children from the PDD-NOS group, and 18 children from the ASD Low-MA 
group. At Time 1, the mean Personal ratio IQ for the AD group was 59.54 (SD = 13.44), 
PDD-NOS was 59.77 (SD = 17.65), and ASD Low-MA was 56.11 (SD = 18.49). At 
Time 2, the mean Personal ratio IQ for the AD group was 54.63 (SD = 17.62), PDD-NOS 
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was 57.09 (SD = 17.49), and ASD Low-MA was 40.07 (SD = 8.53) (Table 7). A mixed 
model design analysis demonstrated a significant interaction between Time 1 diagnosis 
and time-point (Time 1 and Time 2), F(2, 166) = 4.138, p =.018. 
The mean mental growth rates for Personal, which were .50 (SD = .35) for the AD 
group, .56 (SD = .32) for the PDD-NOS group, and .23 (SD = .26) for the ASD Low-MA 
group, were significantly different by group, F(1, 166) = 7.04, p = .001. A post-hoc LSD 
analysis revealed significant differences in Personal progress between the AD and ASD-
Low MA (p = .002) and the PDD-NOS and ASD-Low MA (p < .0005), but not the AD 
and PDD-NOS groups (p = .28) (Table 8). 
Time 1 and Time 2 Domestic data were available for 59 children from the AD 
group, 57 children from the PDD-NOS group, and 12 children from the ASD Low-MA 
group. At Time 1, the mean Domestic ratio IQ for the AD group was 66.60 (SD = 22.17), 
PDD-NOS was 70.17 (SD = 26.40), and ASD Low-MA was 65.46 (SD = 19.05). At 
Time 2, the mean Domestic ratio IQ for the AD group was 63.50 (SD = 32.17), PDD-
NOS was 58.68 (SD = 27.69), and ASD Low-MA was 33.47 (SD = 16.65) (Table 7). A 
mixed model design analysis demonstrated a significant interaction between Time 1 
diagnosis and time-point (Time 1 and Time 2), F(2, 125) = 5.62, p = .005. 
The mean mental growth rates for Domestic, which were .63 (SD = .66) for the 
AD group, .47 (SD = .53) for the PDD-NOS group, and .02 (SD = .23) for the ASD Low-
MA group, were significantly different by group, F(1, 125) = 5.76, p = .004. Levene’s 
test for equality of variances was found to be violated for the present analysis, F(2,125) = 
3.75, p = .026. A Games-Howell post-hoc analysis revealed significant differences in 
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Domestic progress between the AD and ASD-Low MA (p < .0005) and the PDD-NOS 
and ASD-Low MA (p < .0005), but not the AD and PDD-NOS groups (p = .34) (Table 8).  
Time 1 and Time 2 Community data were available for 61 children from the AD 
group, 58 children from the PDD-NOS group, and 11 children from the ASD Low-MA 
group. At Time 1, the mean Community ratio IQ for the AD group was 39.91 (SD = 
25.89), PDD-NOS was 40.72 (SD = 27.85), and ASD Low-MA was 22.11 (SD = 23.57). 
At Time 2, the mean Community ratio IQ for the AD group was 58.20 (SD = 72.08), 
PDD-NOS was 52.72 (SD = 24.40), and ASD Low-MA was 28.20 (SD = 24.67) (Table 
7). A mixed model design analysis did not demonstrate a significant interaction between 
Time 1 diagnosis and time-point (Time 1 and Time 2), F(2, 127) = .323, p =.725. 
The mean mental growth rates for Community, which were .82 (SD = 1.61) for 
the AD group, .67 (SD = .58) for the PDD-NOS group, and .37 (SD = .53) for the ASD 
Low-MA group, were not significantly different by group, F(1, 127) = 1.06, p = .48.  
Socialization: Interpersonal Relationships, Play and Leisure Time, Coping Skills  
Time 1 and Time 2 Interpersonal Relationships data were available for 81 
children from the AD group, 70 children from the PDD-NOS group, and 18 children from 
the ASD Low-MA group. At Time 1, the mean Interpersonal Relationships ratio IQ for 
the AD group was 34.64 (SD = 14.14), PDD-NOS was 44.66 (SD = 17.00), and ASD 
Low-MA was 33.33 (SD = 10.53). At Time 2, the mean Interpersonal Relationships ratio 
IQ for the AD group was 44.04 (SD = 25.95), PDD-NOS was 54.12 (SD = 27.79), and 
ASD Low-MA was 22.54 (SD = 9.86) (Table 7). A mixed model design analysis 
demonstrated a significant interaction between Time 1 diagnosis and time-point (Time 1 
and Time 2), F(2, 166) = 4.719, p =.01. 
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The mean mental growth rates for Interpersonal Relationships, which were .54 
(SD = .55) for the AD group, .66 (SD = .58) for the PDD-NOS group, and .13 (SD = .15) 
for the ASD Low-MA group, were significantly different by group, F(1, 166) = 6.94, p 
= .001. Levene’s test for equality of variances was found to be violated for the present 
analysis, F(2,166) = 5.86, p = .003. A Games-Howell post-hoc analysis revealed 
significant differences in Interpersonal Relationships progress between the AD and ASD-
Low MA (p < .0005) and the PDD-NOS and ASD-Low MA (p < .0005), but not the AD 
and PDD-NOS groups (p = .42) (Table 8). 
Time 1 and Time 2 Play and Leisure data were available for 81 children from the 
AD group, 69 children from the PDD-NOS group, and 17 children from the ASD Low-
MA group. At Time 1, the mean Play and Leisure ratio IQ for the AD group was 36.13 
(SD = 16.79), PDD-NOS was 50.45 (SD = 20.81), and ASD Low-MA was 34.22 (SD = 
21.19). At Time 2, the mean Play and Leisure ratio IQ for the AD group was 40.51 (SD = 
25.72), PDD-NOS was 48.57 (SD = 24.12), and ASD Low-MA was 22.10 (SD = 13.27) 
(Table 7). A mixed model design analysis did not demonstrate a significant interaction 
between Time 1 diagnosis and time-point (Time 1 and Time 2), F(2, 164) = 2.85, p =.061. 
The mean mental growth rates for Play and Leisure, which were .46 (SD = .57) 
for the AD group, .47 (SD = .51) for the PDD-NOS group, and .14 (SD = .25) for the 
ASD Low-MA group, were significantly different by group, F(1, 164) = 3.06, p = .049. 
Levene’s test for equality of variances was found to be violated for the present analysis, 
F(2,164) = 3.55, p = .031. A Games-Howell post-hoc analysis revealed significant 
differences in Play and Leisure progress between the AD and ASD-Low MA (p = .001) 
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and the PDD-NOS and ASD-Low MA (p = .001), but not the AD and PDD-NOS groups 
(p = .99) (Table 8). 
Time 1 and Time 2 Coping data were available for 56 children from the AD group, 
52 children from the PDD-NOS group, and 11 children from the ASD Low-MA group. 
At Time 1, the mean Coping ratio IQ for the AD group was 42.99 (SD = 23.42), PDD-
NOS was 40.34 (SD = 18.33), and ASD Low-MA was 41.47 (SD = 16.33). At Time 2, 
the mean Coping ratio IQ for the AD group was 45.78 (SD = 26.94), PDD-NOS was 
59.07 (SD = 30.05), and ASD Low-MA was 22.38 (SD = 13.62) (Table 7). A mixed 
model design analysis demonstrated a significant interaction between Time 1 diagnosis 
and time-point (Time 1 and Time 2), F(2, 116) = 7.48, p =.001. 
The mean mental growth rates for Coping, which were .50 (SD = .64) for the AD 
group, .82 (SD = .63) for the PDD-NOS group, and .06 (SD = .27) for the ASD Low-MA 
group, were significantly different by group, F(1, 116) = 8.49, p < .0005. Levene’s test 
for equality of variances was found to be violated for the present analysis, F(2,116) = 
3.35, p = .038. A Games-Howell post-hoc analysis revealed significant differences in 
Domestic progress between the AD and ASD-Low MA (p = .002) and the PDD-NOS and 
ASD-Low MA (p < .0005), and the AD and PDD-NOS groups (p = .025) (Table 8). 
Autism Symptomatology by Diagnosis – CARS: 
 A CARS Total score was available at both Time 1 and Time 2 for 103 participants 
in the AD group, 76 in the PDD-NOS group, and 21 in the ASD Low-MA group.  
 At Time 1, the mean CARS Total score was 35.33 (SD = 4.41) for the AD group, 
28.2 (SD = 3.59) for the PDD-NOS group, and 35.12 (SD = 5.69) for the ASD Low-MA 
group. At Time 2, the mean CARS Total score was 30.95 (SD = 7.08) for the AD group, 
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26.76 (SD = 5.79) for the PDD-NOS group, and 36.33 (SD = 4.89) for the ASD Low-MA 
group. A mixed model design analysis demonstrated a significant interaction between 
Time 1 Diagnosis and time-point (Time 1 and Time 2), F(2, 197) = 9.12, p < .0005.  
Due to this significant interaction, a one-way ANOVA was performed to compare 
the AD, PDD-NOS, and ASD Low-MA groups using the change in CARS Total score 
between Time 1 and Time 2 (i.e., Time 2 CARS Total – Time 1 CARS Total = Change in 
CARS Total.). The mean change in CARS Total score was -4.37 (SD = 6.59) for the AD 
group, -1.45 (SD = 5.79) for the PDD-NOS group, and 1.21 (SD = 6.84) for the ASD 
Low-MA group, and was significantly different among groups, F(2, 197) = 9.12, p 
< .0005. A post-hoc LSD analysis revealed significant differences in CARS Total Score 
change between the AD and ASD-Low MA (p < .0005), and AD and PDD-NOS (p 
= .003), but not the PDD-NOS and ASD-Low MA (p = .089) groups (Table 9). 
Autism Symptomatology by Diagnosis – ADOS: 
 An ADOS total score was available at both Time 1 and Time 2 for 82 participants 
in the AD group, 73 in the PDD-NOS group, and 20 in the ASD Low-MA group.  
 At Time 1, the mean ADOS CSS score was 7.89 (SD = 1.79) for the AD group, 
5.66 (SD = 2.16) for the PDD-NOS group, and 7.3 (SD = 1.56) for the ASD Low-MA 
group. At Time 2, the mean ADOS CSS score was 5.9 (SD = 2.57) for the AD group, 
5.05 (SD = 2.75) for the PDD-NOS group, and 7.10 (SD = 2.22) for the ASD Low-MA 
group. A mixed model design analysis demonstrated a significant interaction between 
Time 1 Diagnosis and time-point (Time 1 and Time 2), F(2, 172) = 5.81, p = .004).  
Due to this significant interaction, a 1-way ANOVA was performed to compare 
the AD, PDD-NOS, and ASD Low-MA groups using the change in ADOS CSS score 
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between Time 1 and Time 2. The mean change in ADOS CSS score was -1.99 (SD = 
2.99) for the AD group, -.60 (SD = 2.95) for the PDD-NOS group, and -.16 (SD = 2.12) 
for the ASD Low-MA group, and was significantly different among groups, F(2, 171) = 
5.82, p = .004. A post-hoc LSD analysis revealed significant differences in ADOS CSS 
score change between the AD and ASD-Low MA (p = .014) and the AD and PDD-NOS 
(p = .003), but not the PDD-NOS and ASD-Low MA (p = .55) groups (Table 10). 
Autism Symptomatology by Diagnosis – DSM-IV-TR Ratings: 
DSM-IV: Total 
A DSM Total score was available at both Time 1 and Time 2 for 95 participants 
in the AD group, 74 in the PDD-NOS group, and 23 in the ASD Low-MA group.  
 At Time 1, the mean DSM Total score was 7.15 (SD = 1.05) for the AD group, 
4.2 (SD = .92) for the PDD-NOS group, and 6.35 (SD = 1.85) for the ASD Low-MA 
group. At Time 2, the mean DSM Total score was 5.88 (SD = 2.43) for the AD group, 
4.96 (SD = 2.39) for the PDD-NOS group, and 6.87 (SD = 1.29) for the ASD Low-MA 
group. A mixed model design analysis demonstrated a significant interaction between 
Time 1 Diagnosis and time-point (Time 1 and Time 2), F(2, 189) = 16.69, p < .0005.  
Due to this significant interaction, a 1-way ANOVA was performed to compare 
the AD, PDD-NOS, and ASD Low-MA groups using the change in DSM Total score 
between Time 1 and Time 2. The mean change in DSM Total score was -1.37 (SD = 
2.57) for the AD group, .76 (SD = 2.34) for the PDD-NOS group, and .52 (SD = 1.83) for 
the ASD Low-MA group, and was significantly different among groups, F(2, 191) = 
18.03, p < .0005. A post-hoc LSD analysis revealed significant differences in DSM Total 
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score change between the AD and ASD-Low MA (p = .001), and AD and PDD-NOS (p 
< .0005), but not the PDD-NOS and ASD-Low MA (p = .68) groups (Table 11). 
DSM-IV: Social 
A DSM Social score was available at both Time 1 and Time 2 for 96 participants 
in the AD group, 74 in the PDD-NOS group, and 23 in the ASD Low-MA group.  
 At Time 1, the mean DSM Social score was 3.33 (SD = .69) for the AD group, 
2.04 (SD = .85) for the PDD-NOS group, and 2.91 (SD = .96) for the ASD Low-MA 
group. At Time 2, the mean DSM Social score was 2.4 (SD = 1.28) for the AD group, 
1.65 (SD = 1.22) for the PDD-NOS group, and 2.91 (SD = .73) for the ASD Low-MA 
group. A mixed model design analysis demonstrated a significant interaction between 
Time 1 Diagnosis and time-point (Time 1 and Time 2), F(2, 189) = 6.37, p < .0005.  
Due to this significant interaction, a 1-way ANOVA was performed to compare 
the AD, PDD-NOS, and ASD Low-MA groups using the change in DSM Social score 
between Time 1 and Time 2. The mean change in DSM Social score was -.94 (SD = 1.37) 
for the AD group, -.39 (SD =1.25) for the PDD-NOS group, and .00 (SD = 1.17) for the 
ASD Low-MA group, and was significantly different among groups, F(2, 190) = 6.61, p 
= .002. A post-hoc LSD analysis revealed significant differences in DSM Social score 
change between the AD and ASD-Low MA (p = .002), and AD and PDD-NOS (p = .007), 
but not the PDD-NOS and ASD-Low MA (p = .21) groups (Table 12). 
DSM-IV: Communication 
A DSM Communication score was available at both Time 1 and Time 2 for 65 




 At Time 1, the mean DSM Communication score was 1.96 (SD = .50) for the AD 
group, 1.46 (SD = .53) for the PDD-NOS group, and 1.7 (SD = .47) for the ASD Low-
MA group. At Time 2, the mean DSM Communication score was 1.95 (SD = .95) for the 
AD group, 1.88 (SD = .92) for the PDD-NOS group, and 2 (SD = .60) for the ASD Low-
MA group. A mixed model design analysis demonstrated a significant interaction 
between Time 1 Diagnosis and time-point (Time 1 and Time 2), F(2, 189) = 3.82, p 
= .024.  
Due to this significant interaction, a 1-way ANOVA was performed to compare 
the AD, PDD-NOS, and ASD Low-MA groups using the change in DSM 
Communication score between Time 1 and Time 2. The mean change in Communication 
score was -.04 (SD = 1.11) for the AD group, .42 (SD =1.03) for the PDD-NOS group, 
and .30 (SD = .70) for the ASD Low-MA group, and was significantly different among 
groups, F(2, 190) = 4.65, p = .015. A post-hoc LSD analysis revealed significant 
differences in DSM Communication score change between the AD and PDD-NOS (p 
= .005) groups, but not the AD and ASD-Low MA (p = .16) and PDD-NOS and ASD-
Low MA (p = .646) groups (Table 13). 
DSM-IV: Restricted and Repetitive Behaviors 
A DSM Restricted and Repetitive Behaviors score was available at both Time 1 
and Time 2 for 95 participants in the AD group, 74 in the PDD-NOS group, and 23 in the 
ASD Low-MA group.  
 At Time 1, the mean DSM Restricted and Repetitive Behaviors score was 1.85 
(SD = .82) for the AD group, .7 (SD = .74) for the PDD-NOS group, and 1.74 (SD = 
1.10) for the ASD Low-MA group. At Time 2, the mean DSM Restricted and Repetitive 
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Behaviors Score was 1.55 (SD = .96) for the AD group, 1.43 (SD = .98) for the PDD-
NOS group, and 1.96 (SD = .88) for the ASD Low-MA group. A mixed model design 
analysis demonstrated a significant interaction between Time 1 Diagnosis and time-point 
(Time 1 and Time 2), F(2, 188) = 18.37, p < .0005.  
Due to this significant interaction, a 1-way ANOVA was performed to compare 
the AD, PDD-NOS, and ASD Low-MA groups using the change in DSM Restricted and 
Repetitive Behaviors score between Time 1 and Time 2. The mean change in DSM 
Restricted and Repetitive Behaviors score was -.33 (SD = 1.10) for the AD group, .73 
(SD =1.13) for the PDD-NOS group, and .22 (SD = 1.04) for the ASD Low-MA group, 
and was significantly different among groups, F(2, 190) = 19.42, p < .0005. A post-hoc 
LSD analysis revealed significant differences in DSM Restricted and Repetitive 
Behaviors score change between the AD and ASD-Low MA (p = .033), and AD and 
PDD-NOS (p < .0005), and the PDD-NOS and ASD-Low MA (p = .054) groups (Table 
14). 
Discussion 
 The goal of the current study was to examine the diagnostic stability of Autistic 
Disorder, Pervasive Developmental Disorder, Not Otherwise Specified, and Autism 
Spectrum Disorder, Low Mental Age, and explore the change in developmental level and 
autism symptomatology within each group across time. The children included in this 
study participated in an ongoing study conducted at the University of Connecticut, which 
is assessing the use of the M-CHAT, and its revised version (M-CHAT-R), as an ASD 
screening instrument for children between the ages of 16 to 30 months.  




The majority of the ASD Low-MA group retained an ASD diagnosis at follow-up, 
with five (20%) participants retaining that diagnosis and 19 (76%) receiving an AD 
diagnosis. Only one child (4%) received a non-spectrum diagnosis of Developmental 
Delay, which indicates that despite no longer demonstrating symptoms of autism, this 
participant continued to exhibit significant delays in multiple domains of functioning. 
When including all possible diagnostic outcomes at follow-up, we found a significant 
difference in the diagnostic stability of each group (AD, PDD-NOS, and ASD Low-MA). 
Specifically, the AD group was significantly more likely (86.5%) to receive an ASD 
diagnosis at Time 2 than the PDD-NOS group (73.2%). The ASD Low-MA group (96%) 
had a higher rate of ASD retention than the AD group, but the two groups were not 
significantly different. The PDD-NOS group was significantly less likely than the ASD 
Low-MA group to receive an ASD diagnosis at follow-up. Additionally, the AD (67.6%) 
group was significantly more likely than the PDD-NOS (39%) and ASD Low-MA (20%) 
groups to retain their initial diagnosis versus receiving any other ASD diagnosis or any 
other diagnostic outcome. Finally, the ASD Low-MA group (76%) was significantly 
more likely than the AD (18.9%) and PDD-NOS (34.1%) groups to receive an ASD 
diagnosis different from their initial diagnosis, at follow-up.  
Contrary to our hypothesis, all but one of the 25 participants in the ASD Low-MA 
group received an ASD diagnosis at follow-up. This suggests that the initial symptoms of 
autism observed were stable across time and in fact indicative of an ASD at initial 
evaluation, and not solely a consequence of the absence of typical behavior due to low 
mental age. A majority of these children also receive a diagnosis of AD (n =19, 76%) at 
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follow-up as opposed to ASD Low MA (n = 5, 20%), which indicates that these children 
made enough developmental progress between evaluations to exceed the “below 12 
month age equivalent” criteria to be considered low mental age. As predicted, the AD 
group (86.5%) had a higher likelihood of receiving an ASD diagnosis at follow-up than 
the PDD-NOS group (73.2%), but the rate of ASD retention was high for all groups, 
ranging from 73.2% to 96%. 67.6% of participants in the AD group retained that 
diagnosis, which was significantly greater than the PDD-NOS (39%) and ASD Low-MA 
(20%) groups, and consistent with our predictions.  
These findings demonstrate a high stability of ASD diagnoses across time for all 
groups. The high likelihood of receiving an ASD diagnosis at follow-up within the ASD 
Low-MA group suggests that despite the presence of a low mental age, symptoms of an 
ASD can be accurately identified and are indicative of the presence of a concurrent ASD. 
Additionally, within the ASD Low-MA group, ASD symptomatology remains at follow-
up, even when mental age progress has exceeded the low mental age threshold as defined 
by this study. The higher rate of diagnostic stability in the AD group supports the 
conceptualization of AD as an ASD involving a higher degree of impairment than PDD-
NOS. These results also suggest that the degree of ASD symptomatology is likely higher 
in the ASD Low-MA group at both time points than in the PDD-NOS group, and that the 
degree of ASD-related impairment may be more significant and resulting in this higher 
ASD retention.  
Developmental Progress: Mullen 
The ASD Low-MA group had the lowest mean ratio IQ scores in all four 
subdomains of the Mullen (Receptive Language, Expressive Language, Fine Motor, and 
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Visual Reception), at both time points. The AD and PDD-NOS groups had comparable 
ratio IQ equivalent scores, but the PDD-NOS group had higher mean ratio IQ scores than 
the AD group in all four subdomains of the Mullen, at both time points. Those children 
with ASD Low-MA made significantly less developmental progress in all domains than 
children in the AD and PDD-NOS groups. Across all subdomains, the PDD-NOS group 
had higher developmental progress than the AD group, but these groups did not differ 
significantly in any subdomain. Descriptively, all groups made less than 2 years of 
developmental gains in across all developmental domains during the 2 years between 
evaluations, though the ASD Low-MA group made the lowest gains, with the lowest 
developmental progress ratio in Fine Motor (.27), and highest in Visual Reception (.48). 
These findings supported our hypothesis, in which we had predicted that children with 
ASD Low-MA would make significantly lower gains in all areas of development 
compared to children with AD and PDD-NOS. These results suggest that participants 
who received a diagnosis of ASD Low-MA demonstrated the most significant level of 
developmental impairment at both time points, and made the least amount of progress 
between these time points. While the differences between the AD and PDD-NOS groups 
were not significant, the PDD-NOS group made the greatest amount of gains between 
time points, even approaching a ratio of 1 in several sub-domains (.99 in Visual 
Reception, .99 in Receptive Language). These ratios imply that these participants on 
average made the same amount of growth in mental age, measured in age equivalent 
change between Time 1 and Time 2, as they did in chronological age. The area in which 
each group made the least developmental progress was Fine Motor (AD = .69, PDD-NOS 
= .74, ASD Low-MA = .27), which is compelling to consider alongside prior literature 
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that demonstrated that children with more severely delayed motor skills are less likely to 
move off the spectrum (Sutera et al., 2007).  
Developmental Progress: Vineland 
The results observed on the Vineland and its various subdomains were largely 
consistent with our predictions, as well as the outcomes observed on the Mullen, though 
there were some surprising findings. On the whole, the PDD-NOS group typically 
received the highest ratio IQ scores at both Time 1 and Time 2, followed by the AD 
group, with the ASD Low-MA group receiving the lowest mean ratio IQ scores. The first 
exception to this was the Personal subdomain, for which all three groups had similar ratio 
IQ’s at Time 1, and each group experienced a decrease, rather than increase, in ratio IQ 
across time. Similarly, in the Domestic subdomain, the AD group had the highest ratio IQ 
score at Time 2, and all three groups experienced a decrease in ratio IQ between time 
points. Likewise, in the Community subdomain, the AD group had the highest ratio IQ 
score at Time 2, having experienced an increase in ratio IQ score. The final unexpected 
result was in the Coping domain, where the AD group had a higher ratio IQ at time 1 than 
the PDD-NOS group, but more surprisingly, the ASD Low-MA group also had a 
marginally higher coping rate than the PDD-NOS group. Though these group differences 
are quite small, it was the only observed instance on either developmental measure in 
which the ASD Low-MA group had a score that indicated a higher level of functioning 
than either the AD or PDD-NOS group. The ASD Low-MA group had the lowest ratio of 
developmental progress between evaluations, across all domains of the Vineland. This 
supports the conceptualization of ASD Low-MA as a diagnosis involving severe, highly 
stable developmental delays in several areas of functioning. In some cases, the AD group 
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had a slightly higher progress ratio than the PDD-NOS group, which was contrary to our 
expectations. Past studies have demonstrated consistently that the PDD-NOS group tests 
higher than the AD group in cognitive skills (Cohen et al., 1986; Sevin et al., 1995; 
Walker et al., 2004), but one study that combined AD and PDD-NOS into groups based 
on high versus low IQ, found an interaction between IQ and cognitive scores on adaptive 
functioning (Bolte & Poustka, 2002). These results may imply that while most often there 
are observed differences in cognitive and adaptive ability between PDD-NOS and AD, 
that this is not a blanket standard to be applied to every adaptive domain.  
ASD Symptomatology 
The AD (35.33) and ASD Low-MA (35.12) groups had similar mean CARS Total 
Score at Time 1, with the PDD-NOS (28.2) group having a significantly lower mean 
score. At Time 2, however, the AD group (30.95) demonstrated a notable decrease in 
CARS mean score and the PDD-NOS (26.76) experienced a more modest decrease, while 
the ASD Low-MA group experienced a modest increase (36.33). These findings are 
consistent with the findings of a study conducted by Chlebowski et al. (2010), which 
identified a CARS Total Score of 32 as the cut-off score to distinguish between AD and 
PDD-NOS at Time 1, and a score of 30 at Time 2. Overall, the AD group experienced a 
significantly higher reduction in ASD symptomatology, as compared to the PDD-NOS 
and ASD Low-MA groups. This reduction in ASD symptomatology for the AD group 
demonstrates improvement across time, and this reduction in ASD symptoms could 
potentially be attributed to identification and subsequent implementation and reception of 
intervention services at Time 1. The small decrease in PDD-NOS CARS scores was less 
expected, as was the small increase in ASD Low-MA CARS scores. These changes 
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suggest that the ASD symptomatology in both the PDD-NOS and ASD Low-MA groups 
are more stable across time than the AD group.  
On the ADOS, the observed trends are similar to those observed regarding the 
CARS scores and change across time. At follow-up, the AD group experienced the most 
significant change across time, the PDD-NOS group was less severe than the other 
groups at both time points but experiencing less change, and the ASD Low-MA group 
was the most severe at both time points with little change. For both the CARS and the 
ADOS, it may be that the children with PDD-NOS had a milder ASD symptomatology at 
the time of their initial evaluation, but began expressing a higher number and/or intensity 
of ASD symptoms, particularly the RRBs, by the time of follow-up. 
The change in DSM-IV Total Score was significantly different between the AD (-
1.37) and the PDD-NOS (.76) and ASD Low-MA (.52) groups. These trends are similar 
to those observed on the ADOS and the CARS, with the exception of the PDD-NOS 
experiencing a minor increase in ASD symptomatology on the DSM-IV Total. This could 
be attributed to the nature of the DSM-IV-TR rating sheet itself, in that it does not allow a 
reflection of severity as is built into the CARS and ADOS, but rather an indication of 
whether or not a particular symptom is present or absent.  
The change in DSM-IV Social Score was significantly different between the (-
.94) AD and the PDD-NOS (-.39) and ASD Low-MA (.00) groups. These trends are 
consistent with the previously observed trends on the CARS and ADOS, but distinct from 
the overall trend for the DSM-IV Total Score, in which the PDD-NOS group experienced 
a slight increase in symptomatology. These results demonstrate that the symptoms of 
ASD that affect social functioning are not increasing in the PDD-NOS group, and that 
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this overall increase in ASD symptom severity must be attributed to either the 
Communication or RRB domains.  
The change in DSM-IV Communication Score was significantly different 
between the AD (-.04) group and the PDD-NOS (.42) group. In Communication, the 
PDD-NOS and ASD Low-MA groups actually experienced a relative increase in 
symptoms endorsed, while the AD group was stable across time. These findings are 
consistent with the DSM-IV Total Score, as well as with the assumption that if children 
with PDD-NOS are making progress with regard to Social symptoms of ASDs, that they 
must be experiencing a worsening of symptoms in another domain, in this case 
Communication.  
The change in DSM-IV Restricted and Repetitive Behaviors Score was 
significantly different between all groups, AD (-.33), PDD-NOS (.73) and ASD Low-MA 
(1.04). These trends are similar to those observed on DSM-IV Communication, where 
PDD-NOS and ASD Low-MA are experiencing an increase in symptoms endorsed across 
time, while the AD group experiences a relative decrease. This is indicative that for the 
PDD-NOS group, despite improvements in the Social domain, these children are 
experiencing increased difficulties in the Communication and RRB domains.  
These unexpected changes in the PDD-NOS group, increases in ASD 
symptomatology, may be attributed to those children in this group that receive an AD 
diagnosis at Time 2, as their symptomatology would have increased between time points. 
Particularly, at Time 1, these children may not have been demonstrating as clear deficits 
in Communication, especially if their language were delayed. Also, these children did not 
have to be exhibiting any repetitive or restricted behaviors, as it is not a required criterion 
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for PDD-NOS, and these behaviors may have emerged between time points and resulted 
in a diagnosis of AD at follow-up.  
The overall trends observed across the CARS, ADOS, and DSM-IV were 
somewhat contrary to our predictions. The ASD Low-MA group demonstrated a high 
degree of stability across time on each of these measures, and experienced an increase in 
symptomatology, though small, on all of the aforementioned measures and their 
subdomains, with the exception of the DSM-IV Social subdomain, where they 
experienced no change. The PDD-NOS group consistently demonstrated the least 
severity at all time-points, across all measures, though increases in symptom severity on 
the DSM-IV Total, Social, and RRB subdomains was unexpected. These children may 
have demonstrated mild symptomatology at their initial evaluation, when in reality they 
were not fully expressing symptoms of ASDs that emerged sometime before their follow-
up. Additionally, these children may have received less intensive treatment as a result of 
this milder presentation than the AD group. The AD group experienced the most 
significant decrease in ASD symptoms across all measures, which is surprising given the 
high number of participants (67.6%) that retained the AD diagnosis at follow-up. 
However, a number of these participants in the AD group received a PDD-NOS diagnosis 
(18.9%) or moved off the spectrum (13.5%) entirely, which may explain the significant 
decrease in ASD symptomatology.  
Implications 
 The results of this study demonstrate the difference between the diagnostic 
stability of AD, PDD-NOS, and ASD Low-MA diagnoses between two time points 
(approximately 2 years). A majority of children with ASD Low-MA remain on the autism 
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spectrum at follow-up (96%), with some that continue to demonstrate a low mental age 
(20%), and only one child that no longer demonstrated symptoms of an ASD, but was 
still significantly developmentally delayed (4%). This finding suggests that autism can in 
fact be detected accurately, even in the presence of co-occurring low mental age, and that 
the symptoms of autism are highly stable across time in this group. It also implies that 
children that test with a low mental age at an early time point will likely make cognitive 
gains, such that they are no longer meeting this category at a later time point. A high 
proportion of children in the AD (86.5%) and PDD-NOS (73.5%) groups also received an 
ASD diagnosis at follow-up, highlighting the high rate of diagnostic retention between 
time-points across all ASD diagnoses, ASD Low-MA included. Children with AD had a 
particularly high rate of receiving that same diagnosis at follow-up (67.6%), while the 
PDD-NOS group had a comparable likelihood of receiving PDD-NOS (39%), another 
ASD (34.1%), or a non-spectrum diagnosis (26.8%). The rates of ASD maintenance 
within the PDD-NOS group seems to suggest that it is a conceptually distinct diagnostic 
group from AD, and the even split between outcomes mirrors prior research in which the 
PDD-NOS group can be divided into subgroups based on their symptomatology, 
developmental level, and outcome. The significant portion of children from the PDD-
NOS group that go on to receive AD at follow-up (equal to or less than 34.1%) is similar 
to the rate of children that would not receive a diagnosis under DSM-V criteria. This 
could suggest that perhaps these children are not demonstrating the full array of ASD 
symptoms at initial evaluation, but would still benefit heavily from identification and 
reception of early intervention services. The elimination of the PDD-NOS diagnosis, and 
the introduction of the requirement of Restricted and Repetitive Behaviors could result in 
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a portion of these children that go on to meet criteria for AD at follow-up being missed 
and failing to receive intervention.  
The results of the Mullen are largely consistent with previous research that 
describes children with PDD-NOS as higher cognitively than their AD counterparts. By 
definition, ASD Low-MA should have the lowest measured improvements in these areas, 
which they did in this sample. An unexpected result, however, was the observed decrease 
in Fine Motor Ratio IQ’s at follow-up for all three groups. The developmental progress 
ratio was positive for each group, which suggests that despite having a low ratio IQ 
because of the continuing differences between mental age and chronological age, that 
these individuals on a whole are making some degree of progress between evaluations. 
However, the developmental progress ratio is less than 1.00 for each group, implying that 
all participants are making less progress in mental age than what would be expected by 
the change in actual chronological age between evaluations. This fact would potentially 
explain the decrease in ratio IQ observed at Time 2, since relative to their peers, these 
individuals are not making mental progress equal to the amount of chronological time 
that passes. The developmental progress ratios were relatively high for the AD group, 
with the lowest ratio .69 for Fine Motor, and the highest .99 for Receptive Language. 
This score in Receptive Language suggests that these children able to make the same 
years’ worth of progress in mental age as their change in chronological age, which is 
quite promising for children with AD, a disorder that impacts communication and 
language. Similarly, the PDD-NOS group had a rate of .99 for both the Visual Reception 
and Receptive Language subdomains, with their lowest ratio .74 for Fine Motor. In 
contrast, the ASD Low-MA group had ratios as low as .27 for Fine Motor, .35 for 
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Expressive and .34 for Receptive Language, and .48 for Visual Reception. This suggests 
just how limited the developmental progress is for children in this diagnostic category, as 
these children on average are making only a quarter to one half of the progress expected 
of them between evaluations.  
 The results of the Vineland were largely consistent with trends observed on the 
Mullen, with some unexpected exceptions. The ASD Low-MA group is the lowest 
functioning at both time points for all but one domain at a single time point, which was 
Coping at Time 1, in which they had a higher ratio IQ score than the PDD-NOS group. 
Otherwise, the PDD-NOS group was typically the highest functioning group, with the 
AD group having higher ratio IQ’s than the PDD-NOS group at Time 1 on Coping, and 
on Time 2 for Domestic and Community. These findings are contrary to prior research 
(Walker et al., 2004) in which PDD-NOS has a higher level of functioning than AD in 
every domain without exception. As expected, the AD group also had higher progress 
ratios than the PDD-NOS group in Domestic and Community, but the PDD-NOS group 
had higher progress ratios than AD in every other subdomain. Overall, the ASD Low-MA 
had the lowest progress ratios in every subdomain, which ranged from .02 in Domestic at 
the lowest to .41 in Receptive Language at the highest. This is comparatively low when 
considering the higher progress ratios for both the AD, ranging from .46 in Play and 
Leisure to .82 in Community, and PDD-NOS, ranging from .47 in Play and Leisure to .91 
in Receptive Language, groups. The developmental progress ratios for Language were 
high for the AD (.80 Expressive and .77 Receptive) and PDD-NOS groups (.76 
Expressive and .91 Receptive), which is higher than might be expected due to the 
difficulties with communication and language often present in ASDs. These trends may 
59	
	
be in part influenced by the fact that the Vineland is a parent-based measure, and based 
on subjective ratings of behaviors that the child demonstrates in an environment outside 
of the evaluation. The Vineland itself also increases in the level of sophistication required 
between items as the items progress within each subdomain; as a result it may take less 
development and be more forgiving at the lower end of functioning, and become more 
difficult to receive a higher score in the subdomains as the questions progress. These 
domains may also involve skills that are likely to not improve for children with ASDs 
easily, such as those related to Daily Living Skills and Socialization. These could also 
include skills that are not targeted as part of intervention services at that age, which are 
primarily focused on rehabilitating and teaching more rudimentary behaviors and tasks, 
such as following verbal commands and engaging with others socially, and not answering 
the telephone or observing rules while riding in the car. Other domains also have items 
that are likely to be at a deficit for an individual with an ASD, regardless of 
developmental or diagnostic progress between evaluations. For example, the Domestic 
subdomain included items concerning personal safety, like being careful around hot or 
sharp objects, which are often at a deficit in individuals with ASDs, who may have an 
undersensitivity to pain and poorer appreciation of danger in the immediate environment.  
 A few major trends regarding autism symptomatology emerged across the CARS, 
ADOS, and DSM-IV. Firstly, the AD group experienced a decrease in total CARS score, 
ADOS CSS, and DSM-IV Total score between two time points, a decrease that was 
significantly greater than changes in the PDD-NOS and ASD Low-MA groups. The 
PDD-NOS group experienced a smaller decrease on the CARS and ADOS, and an 
increase in symptom severity on the DSM-IV Total, specifically in the Communication 
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and RRB subdomains. The ASD Low-MA group, in contrast, experienced small increases 
on the CARS and DSM-IV Total, with a minor decrease on the ADOS. This presented an 
interesting trend of improvement in the AD group, compared to relative stability, and 
occasional worsening, of symptom profile among the PDD-NOS and ASD Low-MA 
groups. This high degree of symptom stability provides further support to the legitimacy 
of assigning an ASD diagnosis in the presence of low mental age, suggesting that the 
observed behaviors are in fact indicative of an ASD, and not just a product of a low 
mental age or an absence of developmental milestones. The trend observed earlier, that 
the PDD-NOS group is likely to receive another ASD diagnosis at follow-up, which is 
most likely AD, would help explain an increase in symptom severity on the DSM-IV 
Total.  Additionally, at Time 2 the PDD-NOS group shows an increase in RRB’s, which 
arguably present later in development, and may not have been present at Time 1 (since a 
PDD-NOS diagnosis did not require RRB’s). These very individuals that began to exhibit 
increased RRB’s at follow-up may constitute a significant number of those individuals 
from the PDD-NOS group remained on the ASD spectrum, but did not receive a PDD-
NOS diagnosis at follow-up. The decrease in symptoms in the AD group could suggest 
that the observed effects are a response to being identified and receiving intervention 
services, which in Connecticut consists typically of 15-20 hours per week of intensive 
intervention services for a child with an ASD.  
Limitations  
 There were a number of limitations that must be considered when interpreting the 
findings of this study. While the overall sample size (N=218) is considered large 
compared to many studies, the ASD Low-MA subgroup was significantly smaller (n = 
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25) than both the AD (n = 111) and PDD-NOS (n = 82) groups. This caused the power 
for some analyses to be smaller than anticipated. If each group had a more comparable 
sample size, we would be more confident in the findings that indicate no differences 
between groups; at current, we may not have had adequate sample sizes to detect 
differences for every question we were investigating.  
There was also an unfortunate lack of available data for every participant at both 
initial and follow-up, resulting in missing data in some cases. This likely could have 
reduced the likelihood of detecting an effect, particularly if this data was missing for the 
ASD Low-MA group, due to its small sample size. This is, however, a function of the 
rarity of the ASD Low-MA subtype to begin with, as over the many years this study has 
operated we were only able to collect data at two time points on these 25 participants. 
Overall, these analyses could be revisited in future studies with larger sample sizes.  
Additionally, across all three groups a portion of children who received a Time 1 
evaluation declined a Time 2 evaluation, or the study was unable to contact for a follow-
up. It is quite possible that the parents of these children were not as concerned with their 
child’s development at the time a follow-up evaluation was offered, when compared to 
those that did return for follow-up. If true, this trend may have biased our data, as our 
sample would be comprised of children who were more likely to demonstrate delays or 
symptoms of autism at a follow-up evaluation.  
Another limitation to consider is the time frame of the study. The data included is 
from two time points as part of the study design, at approximately two and four years of 
age. There is no data available past the follow-up evaluation. As a result, we do not have 
potentially informative data regarding the long-term outcomes for these children. 
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Previous research has demonstrated that ASD symptoms, cognitive ability, and adaptive 
skill level changes with age in children with ASDs, which may have occurred further in 
this sample.  
 An additional limitation in this study was the inability to account for the likely 
impact and role of intervention on the diagnostic and developmental outcome for these 
participants. Through participation in this study, each participant in this sample received 
a diagnosis of an ASD at a relatively young age, around two years on average. This 
diagnosis is normally accompanied by a diagnostic report with lengthy recommendations 
for services targeting these symptoms of autism, as well as any developmental delays 
present at time of evaluation. Intervention services are known to make a significantly 
positive impact on autism symptomatology and severity of developmental delay, and it is 
reasonable to think that within this sample, the results at Time 2 reflect some of this 
progress. Within the study, families indicated on history forms at follow-up that each 
participant received some type of intervention, but specific information regarding the 
type of services, as well the intensity and frequency of services, was not always available 
or detailed enough to truly evaluate the impact and quality of services on a child’s 
progress over time. Therefore, we were unable to directly assess if a child’s improvement 
across time was directly related to the services they received, or the increased parental 
understanding of their child’s deficits, or any other factor or combination of factors that 
may have contributed to a child’s progress, or lack thereof, between evaluations.  
 The reliance upon a single measure of development (Mullen) and one measure of 
adaptive skills (Vineland) is also a limitation of the study. These evaluations are 
conducted within a relatively brief, 3-hour time frame. This allows for the assessment of 
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a child’s skill-level and assignment of a diagnosis, but does not necessarily allow for the 
most comprehensive skill-level measurement. The Mullen as a diagnostic tool is not the 
most inclusive and thorough measure of development; there are a number of alternative 
assessments that require higher administration time, but produce a more precise 
assessment of developmental (e.g., The Differential Ability Scales, The Bayley Scales of 
Infant and Toddler Development, The Stanford-Binet Intelligence Skills). However, the 
exceptionally low developmental level of many of these children precludes the use of 
these measures, especially at initial evaluation.   
Future Directions 
 These results support the position that AD, PDD-NOS, and now ASD Low-MA 
are distinct, sub-categories of ASDs. Each group demonstrated a distinct diagnostic 
stability, developmental progress across time, and change in ASD symptomatology. Even 
within these groups, particularly PDD-NOS, there seemed to be further divisions and sub-
categories based on performance at initial evaluation and ultimate outcome at follow-up. 
The results for the PDD-NOS group were particularly compelling, as this group did not 
uniformly have the least impairment in adaptive skill levels and autism symptom severity 
at both time points as expected based on previous research. A significant portion of the 
group received an ASD other than PDD-NOS at follow-up, most likely AD, indicating an 
emergence of new, or worsening of already present, ASD symptoms. This provides 
further, compelling evidence, for the strength of PDD-NOS as a diagnostic category, and 
the potential loss of individuals under the DSM-V criteria who at initial evaluation may 




 The developmental progress rates and ASD symptom improvement in the AD and 
PDD-NOS groups suggests that despite their severe delays and symptomatology at initial 
evaluation, the intensive intervention services that these groups are likely receiving after 
their initial evaluation is helping to address these delays and providing an opportunity to 
make improvements. However, the very low rate of developmental progress, and the 
worsening of ASD symptomatology in the ASD Low-MA group signals the severity of 
this condition, and may merit more intensive services targeting the delays in this 
population. It may also be a function of the role a low mental age plays in being able to 
engage with intervention services and make developmental progress at all.  
There is a clear need for replication of these results, particularly those regarding 
the ASD Low-MA sample, to ensure the reliability of diagnosing an ASD in the presence 
of a low mental age. If these results were to be replicated, it would be of great service to 
the field, and allow clinicians the confidence in diagnosing ASDs, regardless of mental 
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Table 1. Participant Demographics 
 AD Mean Age (months), 
SD, and range (n=111) 
PDD-NOS Mean Age 
(months), SD, and range 
(n=83) 
ASD Low-MA 
Mean Age (months), SD, 
and range (n=25) 
Difference Between 
Groups 
Time 1 27.09 (4.57) 
17.74 – 36.66 
25.88 (4.04) 




F (4, 428) = 3.67, 
p < .006 
 







 Frequency (%) AD Frequency (%) PDD-
NOS 
Frequency (%) ASD 
Low-MA  
 
Participant Gender     
Male 93(83.8%) 65 (78.3%) 20 (80%)  
Female 18 (16.2%) 18 (21.7%) 5 (20%)  
Total 111 83 25 x
2 (2, N = 219) 
= .964, p = .617 
Ethnicity     
White/European American 87(82.1%) 67(84.8%) 19(76%)  
Black/African American 2(1.9%) 4(5.1%) 2(8%)  
Latino/Hispanic 9(8.5%) 5(6.3%) 3(12%)  
Asian 4(3.8%) 3(3.8%) 0  
Biracial 4(3.8%) 0 1(4%)  
Total 106 79 25 x
2 (8, N = 210) = 
7.450, p = .490 
Maternal Education     
 No degree or diploma 3 (4.3%) 2 (3.1%) 0  
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High school diploma or GED 22 (31.4%) 20 (30.8%) 11 (57.9%)  
Vocational or technical degree 5 (7.1%) 5 (7.7%) 0  
Associates degree 6 (8.6%) 6 (9.2%) 0  
College degree 20 (28.6%) 19 (29.2%) 4 (21.1%)  
 Masters Level degree 11(15.7%) 12(18.5%) 4 (21.1%)  
Ph.D., MD, JD level degree 3(4.3%) 1(1.5%) 0  
Total 70 65 19 x
2 (12, N = 154) = 
9.6746, p = .645 
Yearly Income     
<$10,000 6 (9.5%) 1(1.6%) 0  
$10,000-$20,000 10 (15.9%) 13(20.6%) 2 (11.8%)  
$20,000-$30,000 4 (6.3%) 3(4.8%) 0  
$30,000-$40,000 3(4.8%) 5(7.9%) 4 (23.5%)  
$40,000-$50,000 6 (9.5%) 7(11.1%) 2 (11.8%)  
$50,000-$60,000 4(6.3%) 6(9.5%) 2 (11.8%)  
$60,000-$70,000 6(9.5%) 6(9.5%) 0  
$70,000-$80,000 7(11.1%) 7(11.1%) 3(17.6%)  
$80,000-$90,000 7(11.1%) 3(4.8%) 2 (11.8%)  
$90,000-$100,000 5(7.9%) 2(3.2%) 2(11.8%)  
>$100,000 5 (7.9%) 10(15.9%) 0  
Total 63 63 17 x
2 (20, N = 143) = 















Time 2 Diagnosis x2 p Φ (Phi) 
AD PDD-NOS ASD Low-
MA 
DD Other No Dx    
AD 75 (67.7%) 21 (18.9%) 0  2(1.8%) 1 (0.9%) 12 (10.8%) 74.828 <.0005 .506 
PDD-
NOS 
28 (34.1%) 32 (39.0%) 0 9(11.0%) 3 (3.7%) 10 (12.2%) 
ASD 
Low-MA 
18 (72.0%) 1 (4.0%) 5 (20.0%) 1 (1.4%) 0 0 
 
 
Table 3. Diagnostic Stability, AD, PDD-NOS, ASD Low-MA – Autism Spectrum 




Time 2 Diagnosis  
ASD Non-ASD x2 p Φ (Phi) 
AD 96 (86.5%) 15 (13.5%) 9.349 .009 .207 
PDD-NOS 60 (73.5%) 22 (26.8%) 
ASD Low-MA 24 (96.0%) 1 (4.0%) 
 
 
Table 4. Diagnostic Stability AD, PDD-NOS, ASD Low-MA – Retain Diagnosis (Dx), 




Time 2 Diagnosis  
Retain Dx Other ASD Other Dx x2 p Φ (Phi) 
AD 75 (67.6%) 21 (18.9%) 15 (13.5%) 42.29 <.0005 .440 
PDD-NOS 32 (39.0%) 28 (34.1%) 22 (26.8%) 
ASD Low-MA 5 (20.0%) 19 (76.0%) 1 (4.0%) 
 
 
Table 5. Time 1 and Time 2 Mean Ratio IQ Scores: Mullen 
 
 AD PDD-NOS ASD Low-MA 
Average Age 
Equivalent  
Time 1 Time 2 Time 1 Time 2 Time 1 Time 2 
Visual 
Reception 
66.81 (19.86)  74.26 (28.68) 73.33 (17.09) 85.92 (27.74) 40.28 (12.09) 41.72 (20.32)
Fine Motor 73.81 (26.36) 70.37 (22.82) 76.74 (13.99) 75.61 (20.89) 56.73 (14.01) 39.75 (13.05)
Receptive 
Language 
43.78 (23.25) 63.10 (28.62) 54.55 (22.15) 77.01 (29.05) 30.00 (16.14) 32.05 (17.93)
Expressive 
Language 




Table 6. Developmental Progress between Evaluations, AD, PDD-NOS, ASD Low-MA - 











 AD PDD-NOS ASD Low-MA F p 
Visual 
Reception 
.86 (.59) .99 (.51) .48 (.43) 6.693 .002 
Fine 
Motor 
.69 (.43) .74 (.41) .27 (.24) 10.732 < .0005 
Expressive 
Language 
.77 (.52) .85 (.47) .35 (.34) 8.264 < .0005 
Receptive 
Language 
.99 (.60) .99 (.51) .34 (.34) 4.31 .015 
 















 AD PDD-NOS ASD Low-MA F p 
 AD PDD-NOS ASD Low-MA 
 Time 1 Time 2 Time 1 Time 2 Time 1 Time 2 
Expressive 
Language 
38.33 (18.22) 57.67 (60.49) 49.37 (16.72) 62.5 (26.52) 32.27 (12.07) 28.47 (13.39) 
Receptive 
Language 
44.27 (22.13) 60.39 (31.53) 56.73 (23.09) 72.39 (33.92) 33.11 (13.30) 36.50 (24.735)
Personal 59.54 (13.44) 54.63 (17.62) 59.77 (17.65) 57.09 (17.49) 56.11 (18.49) 40.07 (8.53) 
Domestic 66.60 (22.17) 63.50 (32.17) 70.17 (26.40) 58.68 (27.69) 65.46 (19.04) 33.47 (16.65) 
Community 39.91 (25.89) 58.20 (72.08) 40.72 (27.85) 52.72 (24.40) 22.11 (23.57) 28.20 (24.67) 
Interpersonal 
Relationships 
34.64 (14.14) 44.04 (25.95) 44.66 (17.00) 54.12 (27.79) 33.33 (10.53) 22.54 (9.86) 
Play and Leisure 36.13 (16.79) 40.51 (25.72) 50.45 (20.81) 48.57 (24.12) 34.22 (21.19) 22.10 (13.27) 





.80 (1.32) .76 (.48) .24 (.98) 2.628 .075 
Receptive 
Language 
.77 (.62) .91 (.7) .41 (.47) 4.777 .01 
Personal .50 (.35) .56 (.32) .23 (.26) 7.044 .001 
Domestic .63 (.66) .47 (.53) .02 (.23) 5.764 .004 
Community .82 (1.61) .67 (.58) .37 (.53) 1.057 .475 
Interpersonal 
Relationships 
.54 (.55) .66 (.58) .13 (.15) 6.942 .001 
Play and 
Leisure 
.46 (.57) .47 (.51) .14 (.25) 3.062 .049 




Table 9. ASD Symptoms/Severity between Evaluations, AD, PDD-NOS, ASD Low-MA 
– CARS 
 AD PDD-NOS ASD Low-MA F p 
CARS T1 
Total 
35.33 (4.4) 28.2 (3.59) 35.12 (5.69) 9.12 <.0005 
CARS T2 
Total 
30.95 (7.08) 26.76 (5.79) 36.33 (4.89) 
Change in 
CARS 
-4.37 (6.59) -1.45 (5.79) 1.21 (6.84) 
 
 
Table 10. ASD Symptoms/Severity between Evaluations, AD, PDD-NOS, ASD Low-
MA – ADOS 
 AD PDD-NOS ASD Low-MA F p 
ADOS T1 
Total 
7.89 (1.79) 5.66 (2.16) 7.3 (1.56) 5.81 .004 
ADOS T2 
Total 
5.90 (2.57) 5.05 (2.75) 7.1 (2.22) 
Change in 
ADOS 
-1.99 (2.99) -.60 (2.95) -.16 (2.12) 
 
 
Table 11. ASD Symptoms/Severity between Evaluations, AD, PDD-NOS, ASD Low-
MA – DSM-IV Total 
 AD PDD-NOS ASD Low-MA F p 
DSM T1 
Total 
7.15 (1.05) 4.20 (.921) 6.35 (1.85) 16.692 <.0005 
DSM T2 
Total 
5.88 (2.43) 4.96 (2.39) 6.87 (1.29) 
Change in 
DSM 





Table 12. ASD Symptoms/Severity between Evaluations, AD, PDD-NOS, ASD Low-
MA – DSM-IV Social 
 AD PDD-NOS ASD Low-MA F p 
DSM T1 
Total 
3.33 (.69) 2.04 (.85) 2.91 (.96) 6.37 .002 
DSM T2 
Total 
2.40 (1.28) 1.65 (1.22) 2.91 (.733) 
Change in 
DSM 
-.94 (1.37) -.39 (1.25) .00 (1.17) 
 
Table 13. ASD Symptoms/Severity between Evaluations, AD, PDD-NOS, ASD Low-
MA – DSM-IV Communication 
 AD PDD-NOS ASD Low-MA F p 
DSM T1 
Total 
1.96 (.5) 1.46 (.53) 1.70 (.47) 3.82 .024 
DSM T2 
Total 
1.95 (.95) 1.88 (.92) 2.00 (.6) 
Change in 
DSM 
-.04 (1.11) .42 (1.03) .30 (.7) 
 
Table 14. ASD Symptoms/Severity between Evaluations, AD, PDD-NOS, ASD Low-
MA – DSM-IV RRB’s 
 AD PDD-NOS ASD Low-MA F p 
DSM T1 
Total 
1.85  (.82) .70 (.74) 1.74 (1.10) 18.37 <.0005 
DSM T2 
Total 
1.55 (.96) 1.43 (.98) 1.96 (.88) 
Change in 
DSM 





DSM-IV TR  
 
Autistic Disorder (299.00 DSM-IV) 
 
A. A total of six (or more) items from (1), (2), and (3), with at least two from (1), and one 
each from (2) and (3): 
1. Qualitative impairment in social interaction, as manifested by at least two of the 
following: 
o Marked impairment in the use of multiple nonverbal behaviors such as eye to-eye 
gaze, facial expression, body postures, and gestures to regulate social interaction . 
o Failure to develop peer relationships appropriate to developmental level 
o A lack of spontaneous seeking to share enjoyment, interests, or achievements 
with other people (e.g., by a lack of showing, bringing, or pointing out objects of 
interest) 
o Lack of social or emotional reciprocity 
2. Qualitative impairments in communication as manifested by at least one of the 
following: 
o Delay in, or total lack of, the development of spoken language (not accompanied 
by an attempt to compensate through alternative modes of communication such as 
gestures or mime) 
o In individuals with adequate speech, marked impairment in the ability to initiate 
or sustain a conversation with others 
o Stereotyped and repetitive use of language or idiosyncratic language 
o Lack of varied, spontaneous make-believe play or social imitative play 
appropriate to developmental level 
3. Restricted repetitive and stereotyped patterns of behavior, interests, and activities, as 
manifested by at least one of the following: 
o Encompassing preoccupation with one or more stereotyped patterns of interest 
that is abnormal either in intensity or focus 
o Apparently inflexible adherence to specific, nonfunctional routines or rituals 
o Stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or 
twisting, or complex whole-body movements) 
o Persistent preoccupation with parts of object 
B. Delays or abnormal functioning in at least one of the following areas, with onset prior 
to age 3 years: 
 Social interaction 
 Language as used in social communication 




C. The disturbance is not better accounted for by Rett’s Disorder or Childhood 
Disintegrative Disorder. 
 
PDD-NOS (299.80 DSM-IV) 
  
The essential features of PDD-NOS are severe and pervasive impairment in the 
development of reciprocal social interaction or verbal and nonverbal communication 
skills; and stereotyped behaviors, interests, and activities. The criteria for Autistic 
Disorder are not met because of late age onset; atypical and/or sub- threshold 
symptomotology are present.  
 
This category should be used when there is a severe and pervasive impairment in the 
development of reciprocal social interaction or verbal and nonverbal communication 
skills, or when stereotyped behavior, interests, and activities are present, but the criteria 
are not met for a specific Pervasive Developmental Disorder, Schizophrenia, 
Schizotypical Personality Disorder, or Avoidant Personality Disorder. For example, this 
category includes “atypical autism”– presentations that do not meet the criteria for 
Autistic Disorder because of late age of onset, atypical symptomatology, or sub-threshold 
































DSM V  
 
Autism Spectrum Disorder           299.00 (F84.0) 
Diagnostic Criteria 
A.      Persistent deficits in social communication and social interaction across multiple 
contexts, as manifested by the following, currently or by history (examples are illustrative, 
not exhaustive, see text): 
1.       Deficits in social-emotional reciprocity, ranging, for example, from 
abnormal social approach and failure of normal back-and-forth conversation; 
to reduced sharing of interests, emotions, or affect; to failure to initiate or 
respond to social interactions. 
2.       Deficits in nonverbal communicative behaviors used for social 
interaction, ranging, for example, from poorly integrated verbal and nonverbal 
communication; to abnormalities in eye contact and body language or deficits 
in understanding and use of gestures; to a total lack of facial expressions and 
nonverbal communication. 
3.       Deficits in developing, maintaining, and understanding relationships, 
ranging, for example, from difficulties adjusting behavior to suit various 
social contexts; to difficulties in sharing imaginative play or in making 
friends; to absence of interest in peers. 
Specify current severity: 
    Severity is based on social communication impairments and restricted 
repetitive patterns of behavior (see Table 2). 
B.      Restricted, repetitive patterns of behavior, interests, or activities, as manifested by 
at least two of the following, currently or by history (examples are illustrative, not 
exhaustive; see text): 
1.       Stereotyped or repetitive motor movements, use of objects, or speech 
(e.g., simple motor stereotypies, lining up toys or flipping objects, echolalia, 
idiosyncratic phrases). 
2.       Insistence on sameness, inflexible adherence to routines, or ritualized 
patterns or verbal nonverbal behavior (e.g., extreme distress at small changes, 
difficulties with transitions, rigid thinking patterns, greeting rituals, need to 
take same route or eat food every day). 
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3.       Highly restricted, fixated interests that are abnormal in intensity or 
focus (e.g, strong attachment to or preoccupation with unusual objects, 
excessively circumscribed or perseverative interest). 
4.       Hyper- or hyporeactivity to sensory input or unusual interests in sensory 
aspects of the environment (e.g., apparent indifference to pain/temperature, 
adverse response to specific sounds or textures, excessive smelling or 
touching of objects, visual fascination with lights or movement). 
Specify current severity: 
    Severity is based on social communication impairments and restricted, 
repetitive patterns of behavior (see Table 2). 
C.      Symptoms must be present in the early developmental period (but may not become 
fully manifest until social demands exceed limited capacities, or may be masked by 
learned strategies in later life). 
D.      Symptoms cause clinically significant impairment in social, occupational, or other 
important areas of current functioning. 
E.       These disturbances are not better explained by intellectual disability (intellectual 
developmental disorder) or global developmental delay. Intellectual disability and autism 
spectrum disorder frequently co-occur; to make comorbid diagnoses of autism spectrum 
disorder and intellectual disability, social communication should be below that expected 
for general developmental level. 
Note: Individuals with a well-established DSM-IV diagnosis of autistic disorder, 
Asperger’s disorder, or pervasive developmental disorder not otherwise specified should 
be given the diagnosis of autism spectrum disorder. Individuals who have marked deficits 
in social communication, but whose symptoms do not otherwise meet criteria for autism 
spectrum disorder, should be evaluated for social (pragmatic) communication disorder. 
Specify if: 
With or without accompanying intellectual impairment 
With or without accompanying language impairment 
















Diagnostic Criteria for AD, ASD Low-MA, PDD-NOS 
 
Autistic	Disorder		
 
_______ At	least	two	symptoms	in	Cluster	1	(Social)	DSM‐IV‐TR	
checklist	relative	to	developmental	level	
	
AND	
	
_______	 At	least	one	symptom	in	Cluster	2	(Communication)		
	
AND	
	
______			 At	least	one	symptom	in	Cluster	3	(Repetitive	and/or	
Restricted		
	 	 Interests	and	Behaviors)	
	
AND	
	
________	 Child	displays	SIX	OR	MORE	total	symptoms	
	
AND	
	
________	 Onset	was	before	age	three	
	
AND	
	
________	 Child’s	age	equivalence	must	be	12	months	or	higher	on	at	
least	one	of	the	following:	Mullen	Visual	Reception,	
Receptive	Language,	or	Expressive	Language	
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ASD‐Low	MA	
 
________ Child	displays	at	least	1	symptom	from	Cluster	1	(Social)	
‐Must	have	1	symptom	other	than	1b!!	
AND	
________	 Child	displays	at	least	1	other	symptom	from	Cluster	2	
(Communication)		
	 	 and/or	Cluster	3	(Repetitive	and/or	Restricted	Interests	
and	Behaviors)	
AND	
________	 Child’s	Mullen	scores	on	Visual	Reception,	Receptive	
Language,	and		
	 	 Expressive	Language	are	ALL	less	than	or	equal	to	12	
months	AE	 	
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Pervasive	Developmental	Disorder‐	
Not	Otherwise	Specified	(PDD‐NOS)	
 
_______ At	least	one	symptom	in	Cluster	1	(Social)	DSM‐IV‐TR	
checklist	relative	to	developmental	level:	
_______	 CANNOT	include	ONLY	1b	for	Time	1	
evaluations	
AND	
	
_______	 At	least	one	symptom	in	Cluster	2	(Communication)	and/or	
Cluster	3	(Repetitive	and/or	Restricted	Interests	and	
Behaviors)	
AND	
	
________	 Child	does	not	meet	criteria	for	Autistic	Disorder,	
Asperger’s	Disorder,	or	Rett’s	Syndrome	
						AND	
	
________	 Symptoms	noted	on	checklist	cannot	be	better	accounted	
for	by		
another	disorder	(e.g.,	reactive	attachment	disorder,	
sensory	or	motor	impairments,	etc.)	
AND	
	
________	 Child’s	age	equivalence	must	be	12	months	or	greater	on	at	
least	one	of	the	following:	Mullen	Visual	Reception,	
Receptive	Language,	or	Expressive	Language	
													AND	
	
________	 Child	displays	clinically	significant	impairment	in	home,	
school,	and/or	community	settings	
 
 
 
 
 
 
